weighted_error_percent,title,schema_version,publisher,id,completeness_percent,pid,quality_rating,quality_score,weighted_quality_rating,weighted_quality_score,weighted_completeness_percent,error_percent
31.75,National Joint Registry - Primary Elbow Replacement dataset,1.1.7,ALLIANCE > HQIP,0092dc60-a0af-4d45-801c-b888210d6609,26.19,b06415af-9151-4ccc-83a1-ab859943fb2b,Not Rated,47.98,Not Rated,45.23,22.22,30.23
22.22,PTCL Biobank,1.1.7,ALLIANCE > TISSUE DIRECTORY,0121c132-5be6-414e-853b-885ff301854f,69.05,19fa25a7-c15d-441c-b635-ad49043e7a96,Bronze,72.89,Bronze,69.05,60.32,23.26
20.63,Human Developmental Biology Resource (HDBR),1.1.7,ALLIANCE > TISSUE DIRECTORY,01470238-7a17-47a5-a131-17178ba26a0a,69.05,399a6d67-7577-4476-a3b6-4bbceb5a8ff7,Bronze,74.06,Bronze,69.84,60.32,20.93
23.81,Estimating Chronic Respiratory Disease burden in adults in Asian LMICs,1.1.7,HUB > BREATHE,0150353c-d33d-4af0-b177-8ef0adf867f4,52.38,56130df6-1880-4600-a7a4-afa9a4bcc895,Not Rated,64.56,Not Rated,61.11,46.03,23.26
34.92,Paediatric Intensive Care Audit Network - core dataset (admission),1.1.7,ALLIANCE > HQIP,0217114b-6847-4aae-9d76-4d52acea2bcc,26.19,4ca76471-6970-4ad4-87c7-fae77a98cbf5,Not Rated,46.81,Not Rated,43.65,22.22,32.56
39.68,COVID antigen  testing - Pillar 2,1.1.7,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,022cedb4-650d-4566-be41-8d7ed07a5112,66.67,c8f2ee14-2831-445d-a207-2f7f932f4735,Not Rated,64.73,Bronze,67.46,74.6,37.21
38.1,HES Diagnostic Imaging Dataset for CPRD Aurum,1.1.7,ALLIANCE > CPRD,0266f904-b168-488a-a9e7-d318443584ef,69.05,617f9f54-3fb6-40c3-b391-fe51d1fc7c49,Not Rated,65.92,Bronze,69.84,77.78,37.21
20.63,Unscheduled Care Datamart,1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,02dceba1-65c7-49e8-a3e2-05e71c1a3033,80.95,a265af2e-40fc-4759-af61-eab293cdad5a,Silver,80.01,Silver,83.34,87.3,20.93
20.63,Cam-UroOnc Biorepository,1.1.7,ALLIANCE > TISSUE DIRECTORY,0315886c-f34a-4f1d-8f76-2dfa80a6e949,69.05,21044030-1cd5-46b1-b072-c9959fd330b4,Bronze,74.06,Bronze,69.84,60.32,20.93
33.33,The Leicester City and County Chronic Kidney Disease Cohort,1.1.7,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,039c0b29-63f6-4ce9-8d89-87012a52e44f,28.57,4dfec37d-dd24-465f-85ea-30209aff3a26,Not Rated,48.0,Not Rated,45.24,23.81,32.56
25.4,Annual District Death Extract,1.1.7,ALLIANCE > SAIL,03db4df3-f482-4bdd-a335-546ffffbeaab,95.24,15cf4241-abad-4dcc-95b0-8cd7c02be999,Gold,87.16,Gold,87.3,100.0,20.93
33.33,COVIDsortium,1.1.7,OTHER > UNIVERSITY COLLEGE LONDON,03fb3b18-4419-44f7-a035-9ddfecfcadfc,59.52,529f126b-660c-4c31-aeb2-765dac1d9df0,Not Rated,64.64,Bronze,67.46,68.25,30.23
39.68,SOLUS,1.1.7,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,0477b06f-cbed-4949-982e-ce248a47ed1a,16.67,e653b264-3e44-4ed1-a376-86df45db7f72,Not Rated,38.57,Not Rated,37.3,14.29,39.53
36.51,National Cardiac Audit Programme - Myocardial Ischaemia National Audit Project (MINAP),1.1.7,ALLIANCE > HQIP,04b1648d-eeb7-4072-8dd2-806c3ae4e20d,26.19,3558f8a1-6d52-4b59-b513-51c068095bc2,Not Rated,45.66,Not Rated,42.86,22.22,34.88
28.57,North West London COVID-19 Patient Level Situation Report (NWL COVID19 SITREP),1.1.7,HUB > DISCOVER NOW,04f22c93-53df-440a-a71a-50d6827450bc,92.86,ed08c844-343e-44fa-a02d-3ad5ecf25184,Silver,83.64,Silver,84.13,96.83,25.58
20.63,Bowel Screening Wales,1.1.7,ALLIANCE > SAIL,05716e41-9842-4c07-8ddd-af9f9231e056,95.24,9f29d47e-4e9a-41b8-b7bc-5ef3570294ef,Gold,88.32,Gold,89.69,100.0,18.6
20.63,IBD Registry,1.1.7,HUB > GUT REACTION,05eadf79-02a7-4c1f-b1be-93694172a9b3,59.52,a406d06b-350e-4392-ab4e-b1012e422a34,Bronze,69.3,Not Rated,65.08,50.79,20.93
20.63,INCA Trial,1.1.7,ALLIANCE > TISSUE DIRECTORY,0664f988-276e-4268-af43-1986a3101f38,69.05,edd55990-a616-4a9c-a4a2-38af136a349b,Bronze,74.06,Bronze,69.84,60.32,20.93
22.22,CuT-AsthMa: Culturally tailored school-based intervention for asthma in Malaysia,1.1.7,HUB > BREATHE,0692d86c-1f24-43a4-9508-005d00bd7259,54.76,009bcb87-05f3-46e6-8866-7e4df698cb19,Bronze,66.91,Not Rated,62.7,47.62,20.93
20.63,HCV Research UK,1.1.7,ALLIANCE > TISSUE DIRECTORY,069c213c-eb04-463e-a300-7614c03cf623,69.05,01492322-9b33-41cc-9f51-484024e45878,Bronze,74.06,Bronze,69.84,60.32,20.93
25.4,"OMOP dataset: Hospital COVID patients: severity, acuity, therapies, outcomes",1.1.7,HUB > PIONEER,06dee089-8c10-4a8b-aa94-7cb699dc3c80,92.86,0eb789bb-0047-46ac-83ff-631f31e98da0,Silver,83.64,Gold,86.5,98.41,25.58
39.68,Millennium Clinical Events,1.1.7,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,0711cc7e-80d5-4781-a1ab-2637ea176ceb,16.67,5f45bcd1-970b-44ba-8ae2-0fb49b85ffa9,Not Rated,38.57,Not Rated,37.3,14.29,39.53
17.46,Prospective Observation of Fibrosis in the Lung Clinical Endpoints,1.1.7,HUB > BREATHE,0715a950-3999-46d8-a646-6496866638a1,80.95,bb8de9d2-cc38-4c40-b104-ffd167f64f76,Silver,82.34,Silver,76.98,71.43,16.28
28.57,Exome sequencing,1.1.7,UK Biobank,07b82dd5-adc3-42c5-8a60-914042b5bc40,33.33,2ddf0659-f05a-4f1c-b558-63a96e5b49f7,Not Rated,51.55,Not Rated,51.59,31.75,30.23
26.98,The impact of COVID on hospitalised patients with COPD; a dataset in OMOP,1.1.7,HUB > PIONEER,07e3ac82-a38d-45f3-9933-07439f6a761d,76.19,323dc330-aad9-472a-b579-ab66f5f75906,Bronze,74.14,Silver,78.57,84.13,27.91
26.98,Careers Wales dataset,1.1.7,ALLIANCE > SAIL,08846261-45f0-4bcf-9801-fe785dcef1c9,80.95,e4004e0e-6adb-4b11-82c2-af0caf61d751,Silver,77.69,Silver,80.95,88.89,25.58
36.51,Walker Study Data,1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,08a29778-afac-4ae0-86fc-5ca544d53874,21.43,245bffa9-07c3-40b6-916b-161062cdf674,Not Rated,42.11,Not Rated,40.48,17.46,37.21
36.51,Labour Force Survey (Household),1.1.7,NCS > OFFICE FOR NATIONAL STATISTICS,08fd6103-be40-4380-9399-aecaeb216d33,28.57,0b630200-1e7c-4b19-ad53-bcc8863f7ade,Not Rated,46.84,Not Rated,43.65,23.81,34.88
26.98,The acute presentation of pregnant women to non-maternity Emergency departments,1.1.7,HUB > PIONEER,0942304f-8b91-4258-af9c-3a1801c7e79f,73.81,86632207-1e57-4272-b178-ea069a13cae1,Bronze,72.95,Silver,77.78,82.54,27.91
34.92,Paediatric Intensive Care Audit Network - customised data collection,1.1.7,ALLIANCE > HQIP,09586db0-4da4-47f8-9434-13cbd2da2bb9,26.19,6c78af2c-3898-435e-b1f4-e6a44682dc71,Not Rated,46.81,Not Rated,43.65,22.22,32.56
20.63,ICON9 Trial,1.1.7,ALLIANCE > TISSUE DIRECTORY,097cc6bd-ce98-47ec-a73d-5d2c250f2697,69.05,1fdf266c-d5d8-418d-a423-81265da540a2,Bronze,74.06,Bronze,69.84,60.32,20.93
20.63,Development of spirometry predictive values for Indian population,1.1.7,HUB > BREATHE,0985f58b-87e0-42d2-9ee7-efd618abcd51,66.67,59521b01-6adb-4dd3-8b40-dbeb51171e4f,Bronze,74.03,Bronze,68.25,57.14,18.6
15.87,National Records of Scotland (NRS) - Births Data,1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,09d6c72a-7d11-4116-8cf8-6b0da9724bd0,69.05,3b87eef0-bfb6-4bf4-84b9-29880197fec9,Silver,77.55,Bronze,73.02,61.9,13.95
19.05,Reasons for delay in seeking care for pneumonia in children under five,1.1.7,HUB > BREATHE,09e8e407-82b4-4ed4-b296-53810472cbe9,69.05,46f50b9b-b8e2-4ff1-a1b3-779174c3d032,Silver,76.38,Bronze,69.84,58.73,16.28
34.92,Paediatric Intensive Care Audit Network - core dataset (transport),1.1.7,ALLIANCE > HQIP,0a418d30-c13c-404a-9f4c-39334d889b9c,26.19,45310176-6331-4bdd-bc53-d9194e212a35,Not Rated,46.81,Not Rated,43.65,22.22,32.56
23.81,HPB Biobank,1.1.7,ALLIANCE > TISSUE DIRECTORY,0b7ea326-fc05-4aca-a962-3f93128b91d1,69.05,ebe6c9dd-fb95-4301-a929-c21b8077753a,Bronze,72.89,Bronze,68.25,60.32,23.26
36.51,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - clinical audit,1.1.7,ALLIANCE > HQIP,0bb202c7-80e8-4532-8042-1351576e6c94,26.19,3afbb83d-d47b-43b3-a202-0d3081e5d294,Not Rated,45.66,Not Rated,42.86,22.22,34.88
23.81,Tissue Access for Patient Benefit (TAPb),1.1.7,ALLIANCE > TISSUE DIRECTORY,0c50801d-1079-4879-b608-5e8f112b313f,69.05,35985f8e-f01a-41cc-a9e2-30299d3d6eed,Bronze,72.89,Bronze,68.25,60.32,23.26
36.51,Fife Microbiology: Isolations,1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,0c74238f-58b4-42d4-a97a-94737d75a897,21.43,79086e92-cbbf-4615-b642-bc65d8a3bc6d,Not Rated,42.11,Not Rated,40.48,17.46,37.21
36.51,Mental Health Services Data Set - Community,1.1.7,ALLIANCE > NHS DIGITAL,0c98200b-48b5-418a-b8d0-a7708abc1f39,47.62,f3bb6a68-2c32-40a7-9a79-61a718068893,Not Rated,54.05,Not Rated,54.76,46.03,39.53
20.63,Prescribing Information System (PIS),1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,0cb92a4a-cc82-4c33-98f7-06ba93818c50,88.1,22e3943e-edb5-44a1-9e4e-22b0f7a31767,Silver,84.75,Gold,86.51,93.65,18.6
20.63,Research on use of an online learning platform on under-five pneumonia,1.1.7,HUB > BREATHE,0d0ce21e-afc1-4d9f-bf54-e0545363a0cc,66.67,a3d85fd2-9df3-4f6e-9035-0830a3488ddb,Bronze,74.03,Bronze,68.25,57.14,18.6
42.86,Mental Health Services Data Set,1.1.7,ALLIANCE > NHS DIGITAL,0d5bb5b4-ad38-4313-8b19-cd37491c0b41,73.81,fa2ec63d-f76d-4555-8fc1-f4bd66e3c60d,Bronze,67.14,Bronze,69.05,80.95,39.53
20.63,The Cleft Collective,1.1.7,ALLIANCE > TISSUE DIRECTORY,0d6ab9af-c43b-490d-b39c-2d72de46a661,71.43,12288034-00a4-47a8-a779-1cf7a55270e4,Bronze,75.25,Bronze,71.43,63.49,20.93
20.63,MRC Brain Banks Network,1.1.7,ALLIANCE > TISSUE DIRECTORY,0d70b5c8-da5d-49c5-8ff5-0bdc7b5f6306,69.05,6f1b9a4e-2367-47f1-a985-3ed9bf3a7211,Bronze,74.06,Bronze,69.84,60.32,20.93
20.63,Leeds NIHR Biomarker Research Tissue Bank,1.1.7,ALLIANCE > TISSUE DIRECTORY,0d79e0d8-9b3d-4450-9c34-0539673dc9a5,69.05,8648d251-6186-4383-82fc-c036a87c3842,Bronze,74.06,Bronze,69.84,60.32,20.93
31.75,National Neonatal Audit Programme - clinical audit,1.1.7,ALLIANCE > HQIP,0d89c503-1c79-4e2a-baf6-02f12e68805b,26.19,382e897a-77cf-46ca-8d44-d79449ab61df,Not Rated,47.98,Not Rated,45.23,22.22,30.23
34.92,Real Time Data Network (RTDN),1.1.7,HUB > DATA-CAN,0ddcb454-2372-4180-9ba0-a7e1896d4fe2,73.81,616c4488-65a5-4608-a187-0c6bc78b359a,Bronze,69.47,Bronze,72.22,79.37,34.88
33.33,Cancer Registration Data,1.1.7,ALLIANCE > NHS DIGITAL,0e07413c-892c-4f06-bd22-2a917eb5c905,71.43,2ed7bbbc-80db-46c2-a45b-632dda40794b,Bronze,69.44,Bronze,73.02,79.37,32.56
39.68,HES Accident and Emergency data for CPRD Aurum,1.1.7,ALLIANCE > CPRD,0e59698c-1532-4155-ab0e-af11b3d9e7b1,71.43,c43501ec-08b4-4d33-a7dd-d19fca821925,Not Rated,65.95,Bronze,69.84,79.37,39.53
55.56,Mental Health Minimum Dataset v4 (Sensitive) Episodes,1.1.7,ALLIANCE > NHS DIGITAL,0e6e6ed5-ab81-4d7f-b06a-768bf33357ca,64.29,29c61f09-c4a1-425f-9bbc-888c23d99516,Not Rated,56.57,Not Rated,61.11,77.78,51.16
36.51,Tayside Bowel Screening Dataset,1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,0e80170d-de4f-4349-a879-c54a70262736,21.43,00201dde-1faf-41d3-b282-5c24c0ca3697,Not Rated,42.11,Not Rated,40.48,17.46,37.21
22.22,Developing and Evaluating Interventions to Improve Asthma Care,1.1.7,HUB > BREATHE,0e8546e9-c841-4a99-a3f8-bb9020c6782c,54.76,d57d7956-d13e-49c4-bb31-889b8e560596,Bronze,66.91,Not Rated,62.7,47.62,20.93
20.63,Cardamon Clinical Trial Samples,1.1.7,ALLIANCE > TISSUE DIRECTORY,0ecedaa2-e8f5-4eb2-ad3f-fc2ce433fc36,69.05,c0dcceca-c8cf-4269-a0e0-0c18b6ba2de1,Bronze,74.06,Bronze,69.84,60.32,20.93
20.63,UKALL14 Trial,1.1.7,ALLIANCE > TISSUE DIRECTORY,0faa4c3e-edf5-4ae8-9b26-c59c98e26b57,69.05,b5533cb5-0c59-495b-9b11-3c401daeb958,Bronze,74.06,Bronze,69.84,60.32,20.93
42.86,National Radiotherapy Dataset (RTDS) for CPRD Aurum,1.1.7,ALLIANCE > CPRD,0fbd11c2-c44b-430f-b527-63cb82fcee63,47.62,9c535c8d-ebac-4212-b602-fc2489df2c92,Not Rated,50.55,Not Rated,58.73,60.32,46.51
55.56,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Events,1.1.7,ALLIANCE > NHS DIGITAL,0fc61ace-397d-4489-9e62-77f88082e775,64.29,9c8bd383-b117-4167-a25c-9e15fa5ec1c6,Not Rated,56.57,Not Rated,61.11,77.78,51.16
23.81,IBD NIHR BioResource: Health and Lifestyle Questionnaire,1.1.7,HUB > GUT REACTION,1046b837-c4d9-4688-a06e-d7b32d37a161,90.48,18bfe765-5733-41f3-8114-0a1ec2524b5b,Silver,83.61,Silver,85.72,95.24,23.26
39.68,CDE Patient Demographics,1.1.7,ALLIANCE > BARTS HEALTH,10b10bc5-ce28-4cc0-b006-2a0e6d03a72d,21.43,209d7fae-0521-4d07-8a4d-e0843a46a107,Not Rated,40.95,Not Rated,38.89,17.46,39.53
31.75,National Audit of Dementia Round 4 - carer experience survey,1.1.7,ALLIANCE > HQIP,11571357-b9fc-45ed-ab40-3bb3d7443245,26.19,3b5907da-256d-49a3-b24b-00893afe8bdd,Not Rated,47.98,Not Rated,45.23,22.22,30.23
31.75,National Vascular Registry Audit Carotid Lower Limb Amputation clinical dataset,1.1.7,ALLIANCE > HQIP,12690263-f5d3-435b-9582-de1a88064e1e,26.19,03e77b9d-57b8-44d5-8d64-9b1325958b22,Not Rated,47.98,Not Rated,45.23,22.22,30.23
31.75,National Joint Registry - Revision Hip Replacement dataset,1.1.7,ALLIANCE > HQIP,12c5b83c-6e4a-442e-b6c2-2f6b7165fe6b,26.19,4b8286e2-c4e4-4db4-8fd9-5f1c8b4e56de,Not Rated,47.98,Not Rated,45.23,22.22,30.23
22.22,UK primary Sjogren's syndrome Registry,1.1.7,ALLIANCE > TISSUE DIRECTORY,12dba445-dfa9-46af-abc0-5bd3701061a7,69.05,38fe1a10-ebf9-4dc1-8c35-2e7b33b1f6b5,Bronze,72.89,Bronze,69.05,60.32,23.26
22.22,Manchester Eye Tissue Repository,1.1.7,ALLIANCE > TISSUE DIRECTORY,1406c52a-e5d6-4c57-883d-62e405eb604a,69.05,47fc8f03-eba1-4efa-ae3e-148a76b56517,Bronze,72.89,Bronze,69.05,60.32,23.26
34.92,Paediatric Intensive Care Audit Network - core dataset (referral),1.1.7,ALLIANCE > HQIP,148a3896-e4ed-48ef-8643-48df726041e1,26.19,79ae4881-6223-471a-a278-6b2d3b84f971,Not Rated,46.81,Not Rated,43.65,22.22,32.56
34.92,Cystic Fibrosis Patient Sweat Tests,1.1.7,ALLIANCE > CYSTIC FIBROSIS TRUST,148ebbaa-28f4-42e0-a27f-8587e516c3bf,95.24,34f0c2bd-d42e-4441-a89b-e0e384f12afa,Silver,84.83,Silver,82.54,100.0,25.58
33.33,MSDS (Maternity Services Data Set),1.1.7,ALLIANCE > NHS DIGITAL,15123705-7d80-4803-a3b4-d145bf2902c5,80.95,11d3cf0f-ae5d-42f4-a756-b98c3eff46bc,Bronze,74.19,Silver,76.98,87.3,32.56
25.4,Active Adult Survey,1.1.7,ALLIANCE > SAIL,15805559-2115-4822-b91f-635de36fb289,95.24,1eb67fd5-33f6-49dd-a43d-854fff9f25f5,Gold,87.16,Gold,87.3,100.0,20.93
33.33,UHB 2020 Winter Society of Acute Medicine Benchmarking Audit,1.1.7,HUB > PIONEER,1584af1e-9683-4727-8c9b-9bea8beaa68d,80.95,5bf9bf39-3cd7-4a54-994b-9914405f945e,Bronze,75.36,Silver,77.78,88.89,30.23
25.4,GENOMICS ENGLAND 100K QUICK VIEW,1.1.7,GENOMICS ENGLAND,15efea36-d022-495c-a5b6-90f51631a643,95.24,4cc5ed33-3190-4f80-953b-cabd5a2b1c7c,Silver,84.83,Gold,87.3,100.0,25.58
20.63,MFT Biobank,1.1.7,ALLIANCE > TISSUE DIRECTORY,16445ebd-bd45-4ded-a7ae-05f33f676598,71.43,d17efe5d-325f-4fcf-b25e-87d1f6269bea,Bronze,75.25,Bronze,71.43,63.49,20.93
14.29,Child Health Systems Programme - School,1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,164bf6c1-79f2-4ada-98f6-85b7113d4d20,64.29,2c31cb1c-2b3d-40c5-b8d4-bf0b81f089b4,Bronze,75.17,Bronze,71.43,57.14,13.95
20.63,Cambridge Blood and Stem Cell Biobank,1.1.7,ALLIANCE > TISSUE DIRECTORY,167cc04b-23b8-4a9e-9ff9-6c8e07d6a561,69.05,c51ab59a-33ce-4145-a642-7f3f96bca545,Bronze,74.06,Bronze,69.84,60.32,20.93
34.92,NHS 111 Dataset,1.1.7,ALLIANCE > SAIL,16e343ce-61f5-4f04-9fae-4fa6c9babf61,78.57,3d6b69dc-cb3c-4b9a-bdea-a798e7d5b5cf,Bronze,74.17,Bronze,75.39,85.71,30.23
39.68,ARIA Medonc,1.1.7,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,172242ce-a1c5-4915-9c71-686f6e7d5789,16.67,88eb839c-bc51-45f0-b15e-ea89bba9ffca,Not Rated,38.57,Not Rated,37.3,14.29,39.53
28.57,COVID-19 research: Master Dataset,1.1.7,ALLIANCE > BARTS HEALTH,172287c8-05fd-4754-a405-3c18745b73ea,76.19,,Bronze,74.14,Silver,76.99,82.54,27.91
33.33,UHB 2019 Summer Society of Acute Medicine Benchmarking Audit,1.1.7,HUB > PIONEER,1785cc1a-ace0-4980-8352-5977b2b72969,80.95,5acfadf9-21a7-4517-a1b2-620d20469611,Bronze,75.36,Silver,77.78,88.89,30.23
22.22,IoN Trial,1.1.7,ALLIANCE > TISSUE DIRECTORY,17cd75a2-e2b5-440c-89b1-22c9f3b03a03,69.05,e10a660d-b84c-475f-abd4-024dd1af7a5d,Bronze,72.89,Bronze,69.05,60.32,23.26
25.4,Generation Scotland: Scottish Family Health Study,1.1.7,ALLIANCE > GENERATION SCOTLAND,17ff9515-8296-435b-a50e-014168714689,52.38,f4f0ef1a-46cf-4734-8516-3adb0b62ae6d,Not Rated,63.4,Not Rated,59.52,44.44,25.58
25.4,Personal Demographic Service,1.1.7,ALLIANCE > NHS DIGITAL,18028eac-b157-4264-9b86-9928c8e1709a,78.57,f8be6d46-61de-4ed3-b127-76cdf92209d0,Silver,76.5,Silver,80.16,85.71,25.58
42.86,Rural-Urban classification for CPRD GOLD,1.1.7,ALLIANCE > CPRD,1841e7c9-39e1-4eff-9d2f-da3dede71f86,50.0,a7d8c6a8-0825-4e73-8f29-3d76194d7114,Not Rated,51.75,Not Rated,60.31,63.49,46.51
19.05,Asthma and COPD: practices and perceptions of GPs in rural India,1.1.7,HUB > BREATHE,184b973d-ac38-4fc5-8203-f2a244574b4f,66.67,c15bc3ad-c053-496b-863f-1d54075d5bd4,Bronze,75.19,Bronze,69.05,57.14,16.28
33.33,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - case note audit,1.1.7,ALLIANCE > HQIP,18603ae7-a056-4fd6-a3e5-d32a2440dd26,26.19,24b88d1a-4363-4619-870e-9ba9fc5d09e1,Not Rated,46.81,Not Rated,44.45,22.22,32.56
26.98,GENOMICS ENGLAND 100K BIOINFORMATICS DATA,1.1.7,ALLIANCE > GENOMICS ENGLAND,1900af1a-bd21-4157-ac48-203eec682073,95.24,98999c67-0133-4f11-be95-b84ee5727c84,Silver,85.99,Gold,86.51,100.0,23.26
20.63,Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II),1.1.7,HUB > BREATHE,191c1e3f-4eff-41b9-bff1-c6510f7c6c3d,71.43,25bc9862-5b6c-4dda-80b2-46642d9e518a,Silver,76.42,Bronze,69.05,58.73,18.6
36.51,National Asthma and COPD Audit Programme (NACAP): COPD secondary care clinical dataset,1.1.7,ALLIANCE > HQIP,1a0af437-ec80-4db7-9c76-a2418cc8c5c8,26.19,85b4dc84-88f4-4740-80fa-fa1eb04a0ae6,Not Rated,45.66,Not Rated,42.86,22.22,34.88
20.63,UK real-world lymphoid tissue bank,1.1.7,ALLIANCE > TISSUE DIRECTORY,1a412ff0-6275-4cab-a485-bb76befc7afe,71.43,c9f82f86-79e1-4067-932f-5e6dc939006d,Bronze,75.25,Bronze,71.43,63.49,20.93
34.92,Cystic Fibrosis Patient CFQ-R,1.1.7,ALLIANCE > CYSTIC FIBROSIS TRUST,1a4b65e9-5241-4081-9cbb-43a8c8c6ea3b,95.24,9cf5dbd3-a109-4e8d-b1bb-7e4126bd887f,Silver,84.83,Silver,82.54,100.0,25.58
22.22,Air Quality Study: An ecological analysis of asthma health outcomes in Malaysia,1.1.7,HUB > BREATHE,1b80d25c-4f0f-497b-8614-4d1a8c4d1cd3,52.38,95f385b1-4f5c-4a88-8e79-9613acc66938,Not Rated,65.72,Not Rated,61.91,46.03,20.93
38.1,Linked Census and death occurrences,1.1.7,NCS > OFFICE FOR NATIONAL STATISTICS,1bfdab55-3e6a-4b26-bff1-0105ad416cea,76.19,54095c0e-6faa-4de4-ac26-e2c7ef3cba5c,Bronze,70.66,Bronze,73.02,84.13,34.88
31.75,COVID-19 Test Trace and Protect [CTTP],1.1.7,ALLIANCE > SAIL,1c1ada6a-d6e4-4415-a291-81f21acf8f81,76.19,c0fc84af-aeab-4c7e-aa0b-8264baff55d9,Bronze,74.14,Bronze,75.4,82.54,27.91
28.57,NIHR BioResource: Health and Lifestyle Questionnaire,1.1.7,ALLIANCE > NIHR BIORESOURCE,1c3f55ec-d6fc-477e-a1b7-4b8dd43323c6,78.57,321e3ad6-96b9-4f19-bbc4-d06dfe2a59d5,Bronze,75.33,Silver,78.57,85.71,27.91
36.51,Mental Health Services Data Set - Service Users,1.1.7,ALLIANCE > NHS DIGITAL,1d5e3b05-8ce3-4f80-ae3a-f6031ad8cf69,47.62,f48ad0a1-f90c-4a81-8c04-b23f2d8baf7a,Not Rated,54.05,Not Rated,54.76,46.03,39.53
36.51,National Cardiac Audit Programme - National Audit of Percutaneous Coronary Interventions (PCI),1.1.7,ALLIANCE > HQIP,1da704e3-f5ee-4614-8880-10541637a0b7,26.19,ac7016ce-f7a9-4c71-bebb-6af6efa27844,Not Rated,45.66,Not Rated,42.86,22.22,34.88
36.51,Patient SIMD Postcode,1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1db7ce43-0dc3-4fa9-8bc8-14db16aba508,21.43,798567eb-d790-466e-880b-75a1e94ffdf2,Not Rated,42.11,Not Rated,40.48,17.46,37.21
41.27,Somerset Cancer Registry,1.1.7,ALLIANCE > BARTS HEALTH,1e465797-5e54-4667-9120-d373e75be64f,19.05,3ec5f1c4-95c0-4b1d-899b-399cec32ad49,Not Rated,38.59,Not Rated,37.3,15.87,41.86
23.81,NIHR BioResource: SNP imputation data,1.1.7,ALLIANCE > NIHR BIORESOURCE,1fcbb814-10e0-43b7-b383-b5c818090ac8,66.67,39d7ad29-be30-4e12-a7c8-d8757141de85,Bronze,71.7,Bronze,67.46,58.73,23.26
22.22,Patient Episode Dataset for Wales,1.1.7,ALLIANCE > SAIL,2057a9e3-b491-4d8f-874c-9857d00116b0,95.24,4c33a5d2-164c-41d7-9797-dc2b008cc852,Gold,87.16,Gold,88.89,100.0,20.93
30.16,Moorfields Eye Image Dataset Release 001,1.1.7,HUB > INSIGHT,208f79dc-2294-4370-8f16-0d0f7bec9d10,92.86,6bfe44ef-9532-4986-b8a2-9c2cda4a89cc,Silver,82.47,Silver,83.34,96.83,27.91
41.27,South London and Maudsley NHS Foundation Trust (SLaM) Clinical Record Interactive Search (CRIS) platform,1.1.7,ALLIANCE > SLaM,21cd4b8e-f4f5-44a6-83eb-b7799e98ba55,80.95,a25a9892-9141-4e78-8415-945ba73da11e,Bronze,69.55,Not Rated,65.08,71.43,41.86
28.57,Scotland Accident and Emergency,1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,22173c55-25db-4616-97d8-04fdb6899387,83.33,05e6752e-3a0b-4809-aa14-207b4761ef60,Silver,78.88,Silver,80.96,90.48,25.58
20.63,QTL Programme at MRC HGU,1.1.7,ALLIANCE > TISSUE DIRECTORY,22739526-317f-4b0e-a23b-ece0c859958f,71.43,351cc017-caff-4303-8a48-1aa1b90fce2b,Bronze,75.25,Bronze,71.43,63.49,20.93
20.63,Children's Cancer and Leukaemia Group (CCLG) Tissue Bank,1.1.7,ALLIANCE > TISSUE DIRECTORY,227fe0ea-d76e-4c14-a33e-ca255380937d,69.05,c232fa07-5d28-4bdc-b540-1ad8d933c5f9,Bronze,74.06,Bronze,69.84,60.32,20.93
20.63,University of Liverpool - GCP Laboratory Facility,1.1.7,ALLIANCE > TISSUE DIRECTORY,22974866-44c7-4176-9c51-6b57a1dda39d,69.05,029b7f0f-911e-46ce-837f-031959f067da,Bronze,74.06,Bronze,69.84,60.32,20.93
25.4,COG-UK Viral Genome Sequences,1.1.7,ALLIANCE > COVID-19 GENOMICS UK,22e67d6b-3c86-46bc-8472-97ebe70773fa,95.24,1fe02b65-7b77-43bf-93c8-4f0743fee672,Silver,85.99,Gold,87.3,100.0,23.26
31.75,National Joint Registry - Revision Knee Replacement dataset,1.1.7,ALLIANCE > HQIP,23330792-fe18-4331-a101-b246657a03ae,26.19,6664317b-39b9-4133-b6c7-ec4bddf78c76,Not Rated,47.98,Not Rated,45.23,22.22,30.23
36.51,Falls and Fragility Fracture Audit Programme Fracture Liaison Service Database clinical dataset,1.1.7,ALLIANCE > HQIP,237e724d-03b2-478c-a92d-85a1baa6ae53,26.19,d94a604c-5733-4f07-93bb-e77b6ea2313f,Not Rated,45.66,Not Rated,42.86,22.22,34.88
34.92,GENOMICS ENGLAND 100K RARE DISEASE & COMMON,1.1.7,GENOMICS ENGLAND,239e8253-a997-4676-8940-16b74a004365,95.24,3f2b37f1-e8f7-42e5-83c4-fc9e1c58725d,Silver,82.5,Silver,82.54,100.0,30.23
12.7,Idiopathic Pulmonary Fibrosis (IPF) Genome-wide Association Study,1.1.7,HUB > BREATHE,24b82645-1854-438a-97b2-911bba469d3d,80.95,b850e56c-5c5b-413e-b829-743772053978,Silver,84.66,Silver,79.37,71.43,11.63
22.22,SWIFT-RTB,1.1.7,ALLIANCE > TISSUE DIRECTORY,24f2374a-e804-434e-a805-e29b332b0693,69.05,d387ed7c-14fa-49e2-8ced-df0f9372eb88,Bronze,72.89,Bronze,69.05,60.32,23.26
25.4,General Acute Inpatient and Day Case - Scottish Morbidity Record (SMR01),1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,2537007c-9e9e-4441-a0d1-59fa400566c5,83.33,98cda353-0011-45b2-80ca-4ed24cd084bf,Silver,78.88,Silver,82.54,90.48,25.58
19.05,mHealth for pneumonia prevention,1.1.7,HUB > BREATHE,2542abf8-e50b-4962-9fa1-6dba1b7e8439,66.67,fc66381e-cc46-4bca-85fc-fc2ee09cc5dd,Bronze,75.19,Bronze,69.05,57.14,16.28
20.63,Maternity Indicators Dataset,1.1.7,ALLIANCE > SAIL,258c9577-76cd-45c7-a6b5-8e7eed07ce9e,95.24,a0c27454-8cbe-418f-bdae-a85d5e92e9d4,Gold,88.32,Gold,89.69,100.0,18.6
55.56,Mental Health Minimum Dataset v4 (Non-Sensitive) Episodes,1.1.7,ALLIANCE > NHS DIGITAL,263ad0a8-ae90-4c1d-85d6-c3d2470eb2b7,64.29,2964d1b0-2630-468a-82c1-00f5ac901b3d,Not Rated,56.57,Not Rated,61.11,77.78,51.16
55.56,Mental Health Minimum Dataset v2.6 (Sensitive),1.1.7,ALLIANCE > NHS DIGITAL,263f28a4-9835-4856-b1c3-0a0d4085f207,64.29,dc37fcd6-1e68-46e5-b73d-4896e069746a,Not Rated,56.57,Not Rated,61.11,77.78,51.16
20.63,Arden Tissue Bank,1.1.7,ALLIANCE > TISSUE DIRECTORY,263f4ce3-7ccf-45c3-9d41-c1f5ed14cc81,73.81,62fdfd1c-f195-49cc-b3a1-7d9fd2cc8e1b,Silver,76.44,Bronze,72.22,65.08,20.93
20.63,Welsh Cancer Intelligence and Surveillance Unit (WCISU),1.1.7,ALLIANCE > SAIL,265cb00e-1731-4370-b748-203d8bd6c416,95.24,368ad790-3ad8-4f93-9a7c-0bfb64dc6015,Gold,88.32,Gold,89.69,100.0,18.6
19.05,Child Health Systems Programme - 27-30Months Review,1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,26b03931-18ce-4a83-99de-1fca258518f3,76.19,d2d57b7f-95d8-425f-b2fd-cc9aff05e659,Silver,78.8,Silver,81.75,82.54,18.6
25.4,Pathology Data from WRRS,1.1.7,ALLIANCE > SAIL,26da4493-a78b-4090-ba18-e6c600d2c375,95.24,48ef8f54-9606-4e6f-9256-3cc07ffd10b8,Gold,87.16,Gold,87.3,100.0,20.93
22.22,Scottish Human Papillomavirus Archive,1.1.7,ALLIANCE > TISSUE DIRECTORY,270b55a8-a9ee-44ee-8db6-eb214e721eea,76.19,4883530f-1c8d-49aa-886e-ea3b958772ea,Silver,76.47,Bronze,72.22,66.67,23.26
26.98,"Deeply phenotyped sepsis patients within hospital: onset, treatments & outcomes",1.1.7,HUB > PIONEER,273e091c-d0b3-4529-9cd2-4bc1a1b6195a,78.57,38ff49e2-dffa-4103-87a8-386f9f424d22,Bronze,75.33,Silver,79.36,85.71,27.91
36.51,National Asthma and COPD Audit Programme (NACAP): secondary care workstream – children and young people asthma (clinical),1.1.7,ALLIANCE > HQIP,278c3fb2-6b1e-46db-a529-9fc7ddaf4461,26.19,33b36393-3760-40d8-bb98-61806fea5398,Not Rated,45.66,Not Rated,42.86,22.22,34.88
55.56,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Records,1.1.7,ALLIANCE > NHS DIGITAL,2a725f9d-c4a9-4c89-aa37-b3c25cc83389,64.29,7c2b435c-5442-4a05-9b8d-08024ec57c30,Not Rated,56.57,Not Rated,61.11,77.78,51.16
31.75,Admissions & Discharges,1.1.7,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,2aabcea9-d0dd-4780-b162-3c7ed3ee9888,73.81,1d5b9205-dae4-4b0e-a3d3-04707875edf8,Bronze,70.62,Bronze,74.6,80.95,32.56
36.51,Renal Register – ISD National dataset,1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,2ab363bf-3013-475b-8254-bd7740f70edb,21.43,32edd77d-533c-423f-b045-937507f8505d,Not Rated,42.11,Not Rated,40.48,17.46,37.21
26.98,Millennium Cohort Study,1.1.7,ALLIANCE > SAIL,2b09ea87-5b22-4049-b7dd-de0889699115,92.86,a380bd6b-009f-4b78-b638-ba9ee62be2eb,Silver,84.8,Silver,85.72,98.41,23.26
31.75,Leeds-IQVIA Collaboration,1.1.7,HUB > DATA-CAN,2b40a784-79ea-4403-a4bd-0950a7a36a6c,78.57,00b897c7-d50d-486a-af1b-bd94821b58f7,Bronze,73.0,Silver,76.98,85.71,32.56
25.4,UCL Infection DNA Bank,1.1.7,ALLIANCE > TISSUE DIRECTORY,2bd45ffb-b22f-4f02-968b-f5ab8f9d6342,71.43,3e5fb54a-84ec-4888-9a72-4093c6e90dbc,Bronze,72.93,Bronze,69.05,63.49,25.58
31.75,National Joint Registry - Revision Ankle Replacement dataset,1.1.7,ALLIANCE > HQIP,2c0e04bc-2f16-4903-90dc-c9d57ab40efb,26.19,b4f076d2-c9a3-49ba-84f4-94148dc8511a,Not Rated,47.98,Not Rated,45.23,22.22,30.23
20.63,MDSBio,1.1.7,ALLIANCE > TISSUE DIRECTORY,2c3e75c3-141a-4d29-b7f0-0dbe14fb18fd,69.05,13c71637-144e-4742-8aea-aefb778a360e,Bronze,74.06,Bronze,69.84,60.32,20.93
31.75,National Diabetes Inpatient Audit Hospital Characteristics Survey dataset,1.1.7,ALLIANCE > HQIP,2c53d1f7-4540-4c57-8e93-8115b8abc6a9,26.19,a9098b51-f8ec-432e-a52f-f4c1f2c1e4f6,Not Rated,47.98,Not Rated,45.23,22.22,30.23
42.86,Rural-Urban classification for CPRD Aurum,1.1.7,ALLIANCE > CPRD,2d23ad3c-0541-453c-8bf7-9dc42e1aba65,50.0,b7d24b82-f8a4-4838-844c-ecd86ddf5db2,Not Rated,51.75,Not Rated,60.31,63.49,46.51
44.44,Quality of Life of Cancer Survivors in England: Pilot Patient Reported Outcomes Measures Survey (2011) for CPRD Aurum,1.1.7,ALLIANCE > CPRD,2d3302d1-b6fc-4883-8168-010da0d48638,50.0,3a387099-e69e-479d-a937-2cc3795d7170,Not Rated,50.58,Not Rated,59.53,63.49,48.84
30.16,GENOMICS ENGLAND 100K NHSD LINKED DATA,1.1.7,GENOMICS ENGLAND,2d4b933d-1c8b-4fde-860e-c324454d28f9,95.24,14c31b39-f189-4417-bd38-635268495593,Silver,83.66,Silver,84.92,100.0,27.91
23.81,IBD NIHR BioResource: NHS Trust data,1.1.7,HUB > GUT REACTION,2d6e8e68-2fc9-4b9c-a517-c5c5677af225,57.14,ae1898da-7fe5-4fe0-b10d-9f06cdec1735,Bronze,66.94,Not Rated,61.91,47.62,23.26
36.51,Falls and Fragility Fracture Audit Programme National Hip Database Facilities Survey 2019,1.1.7,ALLIANCE > HQIP,2dbd2e38-a4bb-4f8c-b401-ebec10f0d89e,26.19,025c9e8a-938b-4886-9e03-fcad90fe7157,Not Rated,45.66,Not Rated,42.86,22.22,34.88
22.22,"4 Country ChrOnic: estimating respiratory disease burden in adults, South India",1.1.7,HUB > BREATHE,2dc79612-0e0d-4336-aaa1-6abd90d28589,59.52,2f1244b8-7cbf-4fa3-8534-433efd769d48,Bronze,69.3,Not Rated,65.08,52.38,20.93
52.38,Mental Health Dataset (MHDS) for CPRD Aurum,1.1.7,ALLIANCE > CPRD,2e8cc70b-bd57-4b64-bd12-fbc07e0f240f,50.0,48627b2d-f247-4921-9ee1-6c37adfff10d,Not Rated,49.42,Not Rated,55.55,63.49,51.16
31.75,National Audit of Dementia Round 4 - casenote audit,1.1.7,ALLIANCE > HQIP,304430ff-0aff-4d36-91e5-94be251a409a,26.19,587a94e6-48a4-4e5e-8230-4018897bc7c7,Not Rated,47.98,Not Rated,45.23,22.22,30.23
20.63,Watch and Wait Trial,1.1.7,ALLIANCE > TISSUE DIRECTORY,30a0ee0e-d9f9-4341-b00c-2fab8f122b5f,69.05,e46dccbf-484d-45d2-a42a-4d308b87c113,Bronze,74.06,Bronze,69.84,60.32,20.93
33.33,Systemic Anti-Cancer Therapy Dataset [SACT],1.1.7,ALLIANCE > SAIL,3141f405-9653-4189-9a1f-443a463d4b1b,78.57,6c4ed998-0f05-415c-a3e4-42430bb62d24,Bronze,74.17,Silver,76.98,87.3,30.23
26.98,Wales Asthma Observatory,1.1.7,HUB > BREATHE,333d92ca-3a32-41bd-8b16-96aee2dc85b1,95.24,8604bcdc-235a-4c70-b29b-1617396815e6,Silver,85.99,Gold,86.51,100.0,23.26
22.22,TRICON8B,1.1.7,ALLIANCE > TISSUE DIRECTORY,33e4b8c6-23cc-4c5f-a7a5-8380035b6601,69.05,ff875c08-58e6-4e33-8ffe-6f51c8364333,Bronze,72.89,Bronze,69.05,60.32,23.26
36.51,"Deaths – CHI, Community Health Index",1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,33e96a6f-8791-48c7-a440-889dba594c36,21.43,faf2fc49-d09f-4ea2-a2cb-b1d30fffa406,Not Rated,42.11,Not Rated,40.48,17.46,37.21
33.33,National Cancer TRE,1.1.7,HUB > DATA-CAN,34f9be53-2445-439b-8ca4-f151359d7e46,78.57,b5439bc5-8141-4a13-a024-a6db2003b40e,Bronze,71.84,Silver,76.19,85.71,34.88
20.63,BRAIN UK,1.1.7,ALLIANCE > TISSUE DIRECTORY,359006d7-1c6c-43c2-8905-09b016398ae1,71.43,1c455ad3-af51-4b93-aff4-c5d3dacfa9f4,Bronze,75.25,Bronze,71.43,63.49,20.93
55.56,Mental Health Minimum Dataset v3_3.5 (Sensitive),1.1.7,ALLIANCE > NHS DIGITAL,36047c5f-7d57-4d25-a114-2bcc6c11708f,64.29,c123f74c-0731-428e-b31b-eee2723df54d,Not Rated,56.57,Not Rated,61.11,77.78,51.16
36.51,NHS Tayside and Fife Accident & Emergency Dataset (ISD/National),1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,3728b674-68a2-4710-9f8e-b0fc3f2add10,21.43,750063ea-6bfd-4492-9748-2a18080cf6ea,Not Rated,42.11,Not Rated,40.48,17.46,37.21
20.63,Bristol Dental School Saliva Bank,1.1.7,ALLIANCE > TISSUE DIRECTORY,37687806-bab2-4de8-87a7-844a0061e7f8,71.43,8d77f0ad-f376-4d61-a97d-5e996c2bbe72,Bronze,75.25,Bronze,71.43,63.49,20.93
20.63,Exploring psychological issues of primary care teams in Malaysia amidst COVID-19,1.1.7,HUB > BREATHE,37eb2884-d7df-489f-a3ad-f02f1e510475,52.38,64f78a5f-268f-4951-9c91-f7e7130baffa,Bronze,66.89,Not Rated,62.7,46.03,18.6
20.63,UK MND Collections,1.1.7,ALLIANCE > TISSUE DIRECTORY,381413fe-8808-47f8-b8df-e65baa543ae4,71.43,89e2d798-c488-4eaf-a50f-a93616093304,Bronze,75.25,Bronze,71.43,63.49,20.93
33.33,North West London Pathology (NWL PATH),1.1.7,HUB > DISCOVER NOW,38194ca7-57f5-40ff-b463-900e306cd40f,92.86,2c5f3ef6-53f8-42e6-a077-8718261df026,Silver,82.47,Silver,81.75,96.83,27.91
23.81,NIHR Nottingham Digestive Diseases Collection,1.1.7,ALLIANCE > TISSUE DIRECTORY,38254214-35f1-4564-b7bb-aab331732dab,69.05,f20bf814-ee80-4e67-ab00-afff884ddbb4,Bronze,72.89,Bronze,68.25,60.32,23.26
44.44,Civil Registration - Deaths,1.1.7,ALLIANCE > NHS DIGITAL,384176d1-8c17-46e5-8771-7e27fe3b184e,78.57,050163dc-1728-4ac5-a7d9-4dd3ca0ca12a,Bronze,69.52,Bronze,70.63,85.71,39.53
20.63,Congenital Anomaly Register and Information Service,1.1.7,ALLIANCE > SAIL,38468759-3351-4722-9eeb-4c6dc9fa44ce,95.24,6fe7e004-eb51-4c7b-9905-1ec9a4827dca,Gold,88.32,Gold,89.69,100.0,18.6
26.98,Clinical response thresholds (acuity) in acutely unwell patients: onset-outcome,1.1.7,HUB > PIONEER,391ab58c-3412-4fa0-96f6-fdd5ae380b86,78.57,a9018475-452b-4864-bbc3-80eda2067820,Bronze,75.33,Silver,79.36,85.71,27.91
49.21,Bridge file: Hospital Episode Statistics to Diagnostic Imaging Dataset,1.1.7,ALLIANCE > NHS DIGITAL,3935e2fd-0c30-4f56-8388-45a02e0499b4,64.29,2f73575d-23c8-4bb8-87db-115cde076127,Not Rated,58.89,Not Rated,64.28,77.78,46.51
42.86,National Radiotherapy Dataset (RTDS) for CPRD GOLD,1.1.7,ALLIANCE > CPRD,3943e6de-6c32-43dd-8090-16ec9ca0902f,47.62,56a66de8-3470-4a36-ac71-4d5471e72654,Not Rated,50.55,Not Rated,58.73,60.32,46.51
34.92,National Cardiac Audit Programme - Cardiac Rhythm Management (CRM),1.1.7,ALLIANCE > HQIP,395262e7-9846-4d9d-a288-8b0ebea782b9,26.19,3cc81e6c-0c17-4ccd-8202-a9aceb82c989,Not Rated,46.81,Not Rated,43.65,22.22,32.56
31.75,Epilepsy 12 - clinical audit,1.1.7,ALLIANCE > HQIP,3a51b861-026d-45ed-abe6-30d9cc07b516,26.19,1fcaf429-8762-454c-b999-c5fdd757b880,Not Rated,47.98,Not Rated,45.23,22.22,30.23
25.4,Death register,1.1.7,UK Biobank,3a56c317-bf1b-448d-89ab-3421eae3aa18,42.86,722056a5-5fc6-4ad2-8efe-62a80dd6389b,Not Rated,57.48,Not Rated,56.35,38.1,27.91
36.51,National Paediatric Diabetes Audit - Spotlight survey of workforce in Paediatric Diabetes Units,1.1.7,ALLIANCE > HQIP,3a9ab245-5fcc-49a0-ae58-12ebab9b0053,26.19,fe8f8e2c-2f77-464d-9d45-a601cb2f8bf9,Not Rated,45.66,Not Rated,42.86,22.22,34.88
19.05,COVID-19 Detection from Chest X-Rays using Deep Learning,1.1.7,HUB > BREATHE,3aa01779-831e-478f-b4e3-7c111d642b18,64.29,57526718-0a9a-42ad-8b7a-582d9ef96d13,Bronze,74.0,Bronze,68.25,55.56,16.28
25.4,Annual District Birth Extract,1.1.7,ALLIANCE > SAIL,3ab70331-aa54-4f0d-aa95-ea2b95bed9d5,95.24,12a77014-4a77-4eb1-8b26-f49689352d1b,Gold,87.16,Gold,87.3,100.0,20.93
26.98,IBD NIHR BioResource: Consent records,1.1.7,HUB > GUT REACTION,3b0a3b33-dbd5-4cb0-b863-0e1fd80c9a1e,88.1,44ca2cf8-679e-447c-a9eb-55b32159679a,Silver,82.42,Silver,82.54,92.06,23.26
41.27,CDE Surginet Documentation,1.1.7,ALLIANCE > BARTS HEALTH,3b752633-8274-4418-b15b-4502bab03935,19.05,4c4bc482-16f5-462f-8daf-51ec6492074d,Not Rated,38.59,Not Rated,37.3,15.87,41.86
23.81,IBD NIHR BioResource: SNP imputation data,1.1.7,HUB > GUT REACTION,3bb25cba-b4dc-47f1-ab5e-b63f89500612,64.29,7dee2bd6-733a-4b2e-a942-7f9eaf8ebbc2,Bronze,70.52,Bronze,66.66,57.14,23.26
22.22,Tissue Solutions Ltd,1.1.7,ALLIANCE > TISSUE DIRECTORY,3c23941a-42a7-4940-b32f-aea743c0dc2a,71.43,bbcdc352-e0f7-4672-93a7-134bcf5001b1,Bronze,74.09,Bronze,69.84,61.9,23.26
36.51,SICSAG Episodes (Scottish Intensive Care Audit Group),1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,3c9e8226-f12c-4824-9996-29a667b9609c,73.81,6f8182d2-2993-400d-829d-b52cdb324bf3,Bronze,71.79,Bronze,73.02,82.54,30.23
20.63,TwinsUK,1.1.7,ALLIANCE > TISSUE DIRECTORY,3ce4870c-5062-4d01-8801-2cf505b979b7,71.43,19b4cd38-3828-4bb1-a980-4f7420658965,Bronze,75.25,Bronze,71.43,63.49,20.93
33.33,Hospital Episode Statistics Accident and Emergency,1.1.7,ALLIANCE > NHS DIGITAL,3ce8ddf2-c69b-4143-9e39-86c0ac2d8482,78.57,3ddfccc3-ba32-4653-a999-966b8d6c412f,Bronze,73.0,Silver,76.19,85.71,32.56
34.92,Cancer Network Information System - CNIS / CANISC,1.1.7,ALLIANCE > SAIL,3d13bc38-3f7f-4807-8847-2a10d6402dd3,73.81,da91f0eb-1761-485b-8b7f-9121b6a1d004,Bronze,71.79,Bronze,72.22,79.37,30.23
28.57,North West London Outpatient Care Data (NWL OP),1.1.7,HUB > DISCOVER NOW,3d51dc99-c44f-44ff-bdab-da205c5e394e,92.86,9f1df859-f1d0-4f1e-959e-affd05138a25,Silver,83.64,Silver,84.13,96.83,25.58
20.63,Ethical Tissue - University of Bradford,1.1.7,ALLIANCE > TISSUE DIRECTORY,3db58c78-fc8b-49b2-a847-b43fd0184500,69.05,fdf9ac68-fc89-4adf-9a73-3a94a9974aef,Bronze,74.06,Bronze,69.84,60.32,20.93
46.03,Prescribing,1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,3e13c6f0-2760-4ece-b047-77d750d9cdbd,35.71,6d044471-62d2-4190-b315-503f77d33ef2,Not Rated,45.76,Not Rated,50.0,46.03,44.19
33.33,National Clinical Audit of Anxiety and Depression - spotlight audit on psychological therapies (patient experience survey),1.1.7,ALLIANCE > HQIP,3e89692b-7aa2-49d6-b802-82921bd7e006,26.19,d94eb31c-04c4-41b6-ad38-45f6aef30132,Not Rated,46.81,Not Rated,44.45,22.22,32.56
20.63,Multiple Sclerosis and Parkinson's Tissue Bank,1.1.7,ALLIANCE > TISSUE DIRECTORY,3f00330d-1f45-4cab-86c2-e91b7c1a59e9,69.05,4684d391-a6a7-44f7-bf4b-62b6b693f9fa,Bronze,74.06,Bronze,69.84,60.32,20.93
23.81,NIHR BioResource: NHS Trust data,1.1.7,ALLIANCE > NIHR BIORESOURCE,3f1d93ae-792e-4f0c-8cb7-40413b81e132,59.52,3731006a-ee7c-4d15-bc07-4eeb29a3d031,Bronze,68.13,Not Rated,62.7,49.21,23.26
34.92,National Emergency Laparotomy Audit - Patient Audit Dataset,1.1.7,ALLIANCE > HQIP,3f299029-3126-4ce0-893c-4a759cbe90b1,26.19,25b93812-191f-49bb-bbd0-782fb85b2bd2,Not Rated,46.81,Not Rated,43.65,22.22,32.56
36.51,2011 Census variables (and variable breakdowns),1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,3fb06d01-cde5-4e68-b438-cfa0b0f8de9a,78.57,a05aef07-c3fa-4331-905a-6b6f58eac3d5,Bronze,74.17,Bronze,75.39,87.3,30.23
31.75,The impact of ethnicity and multi-morbidity on C19 hospitalised outcomes,1.1.7,HUB > PIONEER,3fc555e1-3e36-46dc-bef1-2d94d560bcb2,78.57,cfa1ef13-8ae0-4827-8a0f-9d2df5244725,Bronze,74.17,Silver,76.98,85.71,30.23
20.63,Cafcass Wales,1.1.7,ALLIANCE > SAIL,3fceb952-0b21-40f4-bd69-fa5cd7ad7df9,95.24,29a714e1-5289-4362-be24-2848c954344e,Gold,88.32,Gold,89.69,100.0,18.6
34.92,Covid-19 UK Non-hospital Antigen Testing Results,1.1.7,ALLIANCE > NHS DIGITAL,401bfb5b-b66b-49e7-931a-280fd6694bbf,76.19,f06ec631-77d0-4b12-a21f-f11e7af49ba5,Bronze,70.66,Bronze,74.6,84.13,34.88
39.68,Endobase,1.1.7,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,40573895-497b-4d47-90e1-6aafe70b93f6,16.67,e830b2a5-14d6-4643-a206-619bf5372dc8,Not Rated,38.57,Not Rated,37.3,14.29,39.53
33.33,Secondary Uses Services Payment By Results,1.1.7,ALLIANCE > NHS DIGITAL,41369771-7b1d-478f-a96c-96c25b637cb2,73.81,2004c512-f7c9-4995-b820-55f36aa3fad2,Bronze,69.47,Bronze,73.81,80.95,34.88
31.75,Domiciliary Social Care Worker [DSCW],1.1.7,ALLIANCE > SAIL,41a667eb-1c84-4665-b0d4-d26405d277c5,71.43,0e38bbf4-c788-4a1a-9af8-a24821250154,Bronze,70.6,Bronze,73.02,77.78,30.23
46.03,Mental Health and Learning Disabilities Data Set,1.1.7,ALLIANCE > NHS DIGITAL,4262e057-6978-4e4c-a05d-c4f328422090,61.9,e9b43936-e700-40c9-8b32-57ed44583f3d,Not Rated,57.7,Not Rated,64.28,74.6,46.51
17.46,Scottish Stillbirth and Infant Death Survey,1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,426c2cfb-3af8-444c-bfae-1b1f78c050ba,71.43,e54d35a6-2e7c-422d-a4a5-a7da930b08f2,Silver,77.58,Bronze,73.81,65.08,16.28
31.75,National Neonatal Audit Programme - 2 year outcomes audit,1.1.7,ALLIANCE > HQIP,4271bc64-b139-40b0-98de-5f2e94e2d026,26.19,3bb02d77-9678-4e6e-832d-c2ed3ede412c,Not Rated,47.98,Not Rated,45.23,22.22,30.23
41.27,HES Patient Reported Outcomes Measures (PROMs) data for CPRD Aurum,1.1.7,ALLIANCE > CPRD,42780b16-32e3-442e-92cd-1810bf30dab8,61.9,7958450d-bd25-42c4-b79e-0e3d0806ac21,Not Rated,61.19,Not Rated,65.08,71.43,39.53
36.51,Cystic Fibrosis Patient Microbiology Cultures,1.1.7,ALLIANCE > CYSTIC FIBROSIS TRUST,42ac7c27-a37b-4081-8a33-51ac077e6a4e,95.24,9c1727f6-2032-413f-bf60-470769b2616e,Silver,83.66,Silver,81.75,100.0,27.91
36.51,Falls and Fragility Fracture Audit Programme National Audit of Inpatient Falls clinical dataset,1.1.7,ALLIANCE > HQIP,430331ef-fa66-485b-b090-e4e83def9136,26.19,3c19e2c9-96d5-45f3-9c55-fc3cec762cd7,Not Rated,45.66,Not Rated,42.86,22.22,34.88
55.56,Mental Health Minimum Dataset v4 (Sensitive) Events,1.1.7,ALLIANCE > NHS DIGITAL,46493a09-b3bb-4c0e-b944-82665ee21508,64.29,9c31a2bd-ff3a-4379-a4b8-0b90527a4c38,Not Rated,56.57,Not Rated,61.11,77.78,51.16
34.92,Census-Mortality-Hospital Episodes Linked Data,1.1.7,NCS > OFFICE FOR NATIONAL STATISTICS,4661db47-82e6-4bc5-80a7-e7a1c3cc96b7,66.67,6064c3a9-e4f1-411b-8181-f1fdca2ab2b8,Bronze,67.06,Bronze,70.63,76.19,32.56
31.75,National Vascular Registry - Organisational Audit dataset,1.1.7,ALLIANCE > HQIP,4678a81d-dfb6-478a-a373-d5510866b3d0,26.19,3c661240-e4d2-456c-a809-133c23f9c469,Not Rated,47.98,Not Rated,45.23,22.22,30.23
36.51,National Cardiac Audit Programme - National Congenital Heart Disease Audit (NCHDA),1.1.7,ALLIANCE > HQIP,46e4c3ba-dae2-453d-832a-88ea603110f1,26.19,2b640175-725a-465f-9aec-6794e6d27791,Not Rated,45.66,Not Rated,42.86,22.22,34.88
31.75,National Vascular Registry Audit - Lower Limb Bypass clinical dataset,1.1.7,ALLIANCE > HQIP,47bec08b-57b7-450e-9be7-af19bab99b58,26.19,d357be1e-27fe-4b2f-9174-3a2a03ecc12b,Not Rated,47.98,Not Rated,45.23,22.22,30.23
20.63,Tayside Biorepository,1.1.7,ALLIANCE > TISSUE DIRECTORY,47d22aea-cbe9-47d4-8f65-45861d9c5f6f,69.05,6ac9b356-00f1-49da-825a-6eb04d18e49d,Bronze,74.06,Bronze,69.84,60.32,20.93
20.63,Theory of Planned Behaviour Intervention: respiratory disease in South India,1.1.7,HUB > BREATHE,47e9fa0a-d74f-43bc-ae63-0eb33f354f01,61.9,7d23e729-72b0-4dd1-820d-07697b49acd0,Bronze,71.65,Bronze,66.67,53.97,18.6
23.81,"St Thomas' Hospitals Plasma, serum & DNA Bio bank from patients with antiphospholipid antibodies",1.1.7,ALLIANCE > TISSUE DIRECTORY,47f57de8-aa71-4df1-af4a-a81e37d4ae8c,71.43,425f4534-51c4-4f75-8ca0-d7c731dbd903,Bronze,72.93,Bronze,69.84,63.49,25.58
26.98,Genotype,1.1.7,UK Biobank,480ccd8a-309e-417a-ac23-5b2d9cd281b1,38.1,93a7352f-fce4-42c9-9a8c-efc7fe23eda0,Not Rated,55.09,Not Rated,53.97,34.92,27.91
28.57,North West London Primary Care Prescriptions Data (NWL PCP),1.1.7,HUB > DISCOVER NOW,48182af6-2ccd-44b2-92d5-69cc140e7d67,92.86,0fb33df6-ab36-4170-9fad-1eaf35a3a812,Silver,83.64,Silver,84.13,96.83,25.58
20.63,Daily Situation Report Data,1.1.7,ALLIANCE > SAIL,4b6d3344-e73a-4f46-8e9d-fabb85827772,92.86,c74a9b9e-1fea-4aac-99fd-54e30668e085,Gold,87.13,Gold,88.89,98.41,18.6
36.51,National Paediatric Diabetes Audit - Spotlight survey of diabetes-related technologies,1.1.7,ALLIANCE > HQIP,4b71fca4-8b2c-4e37-8996-b64a9c1450f0,26.19,eecbdd8d-92a0-4dfd-a216-1cf7f1f8c98f,Not Rated,45.66,Not Rated,42.86,22.22,34.88
20.63,Obesity Research Biobank Syndicate (ORBiS),1.1.7,ALLIANCE > TISSUE DIRECTORY,4cde083a-bf5a-4f57-97c6-38632e10050d,69.05,264a1987-a8cb-4a83-81e0-70b4c3893b7d,Bronze,74.06,Bronze,69.84,60.32,20.93
20.63,POUT-T,1.1.7,ALLIANCE > TISSUE DIRECTORY,4dd3f23c-44be-4126-aac5-ba655d07855c,69.05,c6e0e70e-7f23-4a44-a2cf-1d7d87be7808,Bronze,74.06,Bronze,69.84,60.32,20.93
23.81,COPDMAP Consortium,1.1.7,HUB > BREATHE,505318b6-609c-4baf-9dea-2e3532f936f8,61.9,bcbc41cb-99f7-482e-ba3d-561164abbd4e,Bronze,69.32,Not Rated,63.49,50.79,23.26
33.33,National Audit of Psychosis - Audit on Early Intervention in Psychosis services -  patient experience survey,1.1.7,ALLIANCE > HQIP,50631db6-126e-4b3a-8035-444b66ba4afa,26.19,c3e63860-bd61-4154-ab5f-ca927fb029c4,Not Rated,46.81,Not Rated,44.45,22.22,32.56
42.86,RAPID (Hospital Stay Level Data),1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,50e341b3-11cb-4ea3-afd0-be193c0df91f,73.81,1fc57971-5af5-499e-a500-4ffbb087f0c4,Bronze,69.47,Bronze,69.05,80.95,34.88
39.68,Outpatient Appointment Dataset,1.1.7,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,510e1782-1650-4342-9c20-185ca47f7b11,16.67,1c27bfbf-c659-42ff-8afe-d58250b49c07,Not Rated,38.57,Not Rated,37.3,14.29,39.53
39.68,Covid Vaccination Dataset (CVVD),1.1.7,ALLIANCE > SAIL,511b96dd-3808-4131-9755-252944784f52,76.19,471f101c-a45e-4620-8710-be3036a46fba,Bronze,71.81,Bronze,70.64,80.95,32.56
31.75,COVID-19 SARI-Watch (formerly CHESS),1.1.7,ALLIANCE > NHS DIGITAL,511f73b6-5181-408d-ae40-69b0ef70e732,76.19,f61f116d-f732-450e-9d34-c6ae00e3fd1e,Bronze,72.98,Silver,76.19,84.13,30.23
41.27,ARIA Dataset,1.1.7,ALLIANCE > BARTS HEALTH,5271131b-ba5b-452d-b230-077094a031c2,19.05,621dd611-adcf-4434-b538-eecdbe5f72cf,Not Rated,38.59,Not Rated,37.3,15.87,41.86
38.1,NIHR BioResource: SNP chip data,1.1.7,ALLIANCE > NIHR BIORESOURCE,52a467b0-5401-4818-9c16-2e41d68704c1,78.57,c388676c-a5e5-419c-967c-239c1f0c3c5c,Bronze,73.0,Bronze,73.8,85.71,32.56
33.33,North West London Adult Social Care Data (NWL ASC),1.1.7,HUB > DISCOVER NOW,535a0983-6618-4211-a939-ae2edfe26f9a,92.86,de9cf0f5-b26a-4363-9df8-3628a4aa6b6e,Silver,82.47,Silver,81.75,96.83,27.91
31.75,National Audit of Care at the End of Life - organisational level audit,1.1.7,ALLIANCE > HQIP,535fbfd4-34f0-436d-8de2-e708fd0fa103,26.19,a290592c-a6f5-4874-b283-1d33e923c487,Not Rated,47.98,Not Rated,45.23,22.22,30.23
26.98,Ventilatory strategies and outcomes for patients with COVID: a dataset in OMOP,1.1.7,HUB > PIONEER,53b7c446-667b-409e-920e-67cb516de3ae,73.81,cacba424-6c2c-4b57-8f5b-64e92a78370a,Bronze,72.95,Silver,77.78,82.54,27.91
33.33,COVID19 Vaccination Status,1.1.7,ALLIANCE > NHS DIGITAL,53daaea6-46e8-4665-b50d-5c86396b3bbf,71.43,98372a87-f3e6-475d-be12-46c0f9587413,Bronze,69.44,Bronze,73.81,80.95,32.56
36.51,Business Impact of COVID-19 Survey (BICS),1.1.7,NCS > OFFICE FOR NATIONAL STATISTICS,542baa13-5d19-424e-b747-b2e57922df01,76.19,8e739a01-bcfa-4b75-b7f8-e694ee185f8d,Bronze,71.81,Bronze,73.02,82.54,32.56
20.63,Epilepsy Society Brain and Tissue Bank,1.1.7,ALLIANCE > TISSUE DIRECTORY,54a7dd45-d6c7-4b4d-801d-2becd2b694f1,69.05,f13258c3-f85a-4772-b42e-da8a84c5064a,Bronze,74.06,Bronze,69.84,60.32,20.93
31.75,National Vascular Registry - Lower Limb Angioplasty clinical dataset,1.1.7,ALLIANCE > HQIP,5536b00a-fb31-4e91-9bd8-e7f774974846,26.19,c8b6c319-239b-4792-9898-644a63d07ab5,Not Rated,47.98,Not Rated,45.23,22.22,30.23
23.81,National Community Child Health Database (NCCHD),1.1.7,ALLIANCE > SAIL,553a0fcb-6bed-493c-a185-fa97dc5f370d,95.24,20fe153c-a5e5-4991-900e-8fa9988e771a,Silver,85.99,Gold,88.09,100.0,23.26
19.05,Care-seeking practices for childhood pneumonia in non/tribal areas of Pune India,1.1.7,HUB > BREATHE,561b8a79-6bac-4ffc-91f4-0bbec4e90968,61.9,4346676d-6108-47de-b579-6cef74c6acef,Bronze,72.81,Bronze,67.46,53.97,16.28
20.63,LBIH Biobank,1.1.7,ALLIANCE > TISSUE DIRECTORY,567b23fe-abf2-4e2e-88f7-505dfeaa3cde,69.05,c0318a31-a32c-4d3a-9591-dfe9352bf2b9,Bronze,74.06,Bronze,69.84,60.32,20.93
25.4,"Diabetic Eye Screening: the Birmingham, Solihull and Black Country Data Set",1.1.7,HUB > INSIGHT,56c3aabb-cb99-4da9-a6ed-3212c02e6f20,73.81,36886b21-12ff-45e7-82bc-fb5308c12450,Bronze,74.12,Silver,77.78,80.95,25.58
22.22,TNT: Triple Negative breast cancer Trial,1.1.7,ALLIANCE > TISSUE DIRECTORY,56f3e791-a204-4f67-a4d0-52803148d71a,69.05,5f4c825d-d6c3-453e-9667-8cdf2329b6e1,Bronze,72.89,Bronze,69.05,60.32,23.26
36.51,Tayside & Fife Diabetes – Summary and a range of diabetes related datasets.,1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,5852d8bc-d721-4daf-a63b-21aebcc6f5a9,21.43,49e63323-e564-48ac-9f11-cf77bf0fe20b,Not Rated,42.11,Not Rated,40.48,17.46,37.21
19.05,Labour Force Survey (Longitudinal),1.1.7,NCS > OFFICE FOR NATIONAL STATISTICS,598989e4-17b7-4730-87af-b7e6b1519301,57.14,4ac15572-fe9a-46d3-860d-a46b616181f7,Bronze,69.27,Not Rated,65.87,50.79,18.6
33.33,National Clinical Audit of Anxiety and Depression - spotlight audit on psychological therapies (therapist survey),1.1.7,ALLIANCE > HQIP,59bc96f9-69b7-4763-81a8-ec4695b6b55e,26.19,bf2d780d-936b-4f4c-88f9-a280b849b652,Not Rated,46.81,Not Rated,44.45,22.22,32.56
31.75,Enhanced Prescribing Database,1.1.7,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,5ae869f8-b6af-41c0-bca0-1fffef112375,69.05,2843087f-23a4-4cfe-8e72-53f2b9562cc3,Bronze,68.25,Bronze,73.02,77.78,32.56
34.92,MATCH,1.1.7,ALLIANCE > HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,5b99795a-3db4-4020-a8f9-aa64bcc2c5f0,59.52,5429fc2a-3d72-414d-9393-4079c4c6c0fa,Not Rated,64.64,Bronze,66.66,68.25,30.23
33.33,North West London Accident and Emergency Data (NWL A&E),1.1.7,HUB > DISCOVER NOW,5b9b7964-615b-438a-b151-d2f884a24aee,92.86,721db252-8069-433d-bb6d-4b44b243d364,Silver,82.47,Silver,81.75,96.83,27.91
20.63,VinCaP,1.1.7,ALLIANCE > TISSUE DIRECTORY,5bb40472-fc5d-4b16-a0a6-d1d42fd1d3e8,69.05,e57dd7a2-3c5c-4285-8001-8e2589c395e9,Bronze,74.06,Bronze,69.84,60.32,20.93
33.33,International Severe Asthma Registry,1.1.7,HUB > BREATHE,5c7ae78d-53e6-427d-a3a9-52538f8342dc,52.38,9711e6cc-426c-4cef-afb3-64382f8d7ed4,Not Rated,59.91,Not Rated,54.77,42.86,32.56
11.11,SpiroMeta Consortium Dataset,1.1.7,HUB > BREATHE,5d2758c6-b315-421f-9971-9df8ba83a2d4,78.57,fb6d98c5-e41d-4804-bb28-839556e0f657,Silver,84.63,Silver,79.37,69.84,9.3
33.33,Diagnostic Imaging Dataset,1.1.7,ALLIANCE > NHS DIGITAL,5d76d094-446d-4dcc-baa1-076095f30c23,78.57,86f46be3-bc29-4820-8363-de6530a94c6f,Bronze,73.0,Silver,76.19,85.71,32.56
39.68,ARIA Radonc,1.1.7,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,5e022f8f-4d07-44bb-a87c-43e31200fe1e,16.67,59d72237-6969-4f59-9e87-48138978abe8,Not Rated,38.57,Not Rated,37.3,14.29,39.53
30.16,North West London Mental Health Data (NWL MH),1.1.7,HUB > DISCOVER NOW,5e19a471-64e3-4aa4-ac56-6901d5e39e28,92.86,2d3ec99a-a087-4355-8539-5a22cef58910,Silver,84.8,Silver,83.34,96.83,23.26
25.4,Emergency Department Dataset Daily,1.1.7,ALLIANCE > SAIL,5e2a7277-dc64-499a-b16d-51850d9ad00b,95.24,fa257aa8-51fc-4eb7-a448-e473fa54686d,Gold,87.16,Gold,87.3,100.0,20.93
36.51,National Paediatric Diabetes Audit - core clinical dataset (care processes and outcomes),1.1.7,ALLIANCE > HQIP,5ea9c568-b850-4589-bcbb-6ee0cfd322cd,26.19,e355c9b9-44f0-4ba3-a872-645aa88f4f2b,Not Rated,45.66,Not Rated,42.86,22.22,34.88
31.75,National Maternity and Perinatal Audit Organisational Survey 2019,1.1.7,ALLIANCE > HQIP,600be397-211b-4f65-9f82-e85f4393fb8a,26.19,01ad25ed-8cde-43d7-bc77-d8cc3d165df4,Not Rated,47.98,Not Rated,45.23,22.22,30.23
30.16,North West London population data (NWL POP),1.1.7,HUB > DISCOVER NOW,601f1504-2706-405b-94cb-8cd14231f434,95.24,1032850f-7631-4d9e-a760-b0532bffd21a,Silver,84.83,Silver,84.92,100.0,25.58
20.63,STAMPEDE,1.1.7,ALLIANCE > TISSUE DIRECTORY,60b148f7-b48c-49c4-9286-b83691cfc7b2,69.05,71eb0192-1124-4b27-86e4-1139e0047a02,Bronze,74.06,Bronze,69.84,60.32,20.93
31.75,National Clinical Audit of Anxiety and Depression - Core audit of practice,1.1.7,ALLIANCE > HQIP,61cf3b8d-5a1b-4241-aaac-89599bf17ab6,26.19,4a96b9bf-beb0-41b1-9211-e6ce39a21c1a,Not Rated,47.98,Not Rated,45.23,22.22,30.23
33.33,Census 2011 E&W - Household structure for COVID-19 models,1.1.7,NCS > OFFICE FOR NATIONAL STATISTICS,62087504-c04e-4382-9c71-e1c9b83d2d5e,76.19,2f66bcf9-e626-4e8d-bc6e-2d3958e709d8,Bronze,71.81,Bronze,75.4,84.13,32.56
34.92,Emergency Care Data Set (ECDS),1.1.7,ALLIANCE > NHS DIGITAL,621008c7-67ac-4e3d-9c54-af87cc2f9579,73.81,7749d90e-dd7a-4697-8a9c-666491c64a0c,Bronze,69.47,Bronze,73.02,80.95,34.88
23.81,Scottish Birth Record (SBR),1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,621576c2-a995-424b-a506-2276f9b03f37,80.95,81c53293-ef64-4507-8fcf-2a254dc19936,Silver,80.01,Silver,81.75,87.3,20.93
17.46,ICT-based intervention for adult asthma with limited health literacy,1.1.7,HUBS > BREATHE,62824365-480a-4d20-9ab2-7e7739e7e2ec,71.43,1d6b02f1-47b8-42ad-919d-f738b545cff7,Silver,78.74,Bronze,71.43,60.32,13.95
30.16,GENOMICS ENGLAND 100K PHE LINKED DATA,1.1.7,GENOMICS ENGLAND,62c01293-83a5-4d4d-9d36-9d7aa2bf120f,95.24,ea748742-568a-46e2-b603-2fada49024e1,Silver,83.66,Silver,84.92,100.0,27.91
17.46,COVID-19 Symptom Tracker Dataset,1.1.7,ALLIANCE > SAIL,6325125b-6157-4c20-8bc0-54e2c45cf19b,95.24,594cfe55-96e3-45ff-874c-2c0006eeb881,Gold,89.48,Gold,91.27,100.0,16.28
36.51,SICSAG Daily (Scottish Intensive Care Audit Group),1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,63f9444f-d23b-425c-9ee5-aa09968afa08,73.81,811a54fb-8b79-442f-8e28-a725a0561a15,Bronze,71.79,Bronze,73.02,82.54,30.23
31.75,National Audit of Dementia Round 4 - organisational checklist,1.1.7,ALLIANCE > HQIP,64a0ba4d-776c-4979-a4b0-1f1fb6b61c85,26.19,0a305b29-cf23-4261-9299-5251e41ee9f0,Not Rated,47.98,Not Rated,45.23,22.22,30.23
26.98,Higher Education Statistics Agency (HESA) Student Data,1.1.7,ALLIANCE > SAIL,64c6a583-f71b-478e-a26b-5e581226ec6d,90.48,68b04d3b-17b4-4a04-a8a3-e2a93ed231df,Silver,83.61,Silver,84.92,96.83,23.26
25.4,Diagnostic and Therapy Services Waiting Times,1.1.7,ALLIANCE > SAIL,65c8a30c-de2c-47bf-87e4-18c86e75e54a,92.86,97896866-ab5e-408a-ac5a-072802db9faf,Silver,85.97,Gold,86.5,98.41,20.93
20.63,interNational Anaplastic Thyroid Cancer Tissue Bank (iNATT),1.1.7,ALLIANCE > TISSUE DIRECTORY,6620b221-6909-4106-a49e-f1b5820be2f3,69.05,5ef75d71-73ce-4451-9d7a-a39dd82b712f,Bronze,74.06,Bronze,69.84,60.32,20.93
39.68,The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) primary care sentinel network and database,1.1.7,ALLIANCE > ROYAL COLLEGE OF GENERAL PRACTITIONERS,664513d6-d766-461d-a69e-206a928cd14f,92.86,d5049af5-e351-4b22-8f75-6f3dfc96419b,Silver,78.99,Silver,78.58,96.83,34.88
25.4,Critical Care Dataset,1.1.7,ALLIANCE > SAIL,67ae329c-f51e-4a28-9a1c-e35d2819a6c3,95.24,1789286a-deaf-49df-88cd-660e92934af6,Gold,87.16,Gold,87.3,100.0,20.93
15.87,Genetics of Asthma Severity & Phenotypes,1.1.7,HUB > BREATHE,67cd0c2b-3944-4bc4-a03a-4081ee67847f,80.95,6277abc6-c039-4886-8489-d4a2cdb8190c,Silver,82.34,Silver,77.78,71.43,16.28
25.4,COVID-19 Shielded People list,1.1.7,ALLIANCE > SAIL,67ef8ade-51e6-4737-acee-be871751a698,95.24,dc22db56-8791-4e96-9ce6-6b6a58b1241f,Gold,87.16,Gold,87.3,100.0,20.93
22.22,Exploring the provision of supportive care for patients with COPD in Malaysia,1.1.7,HUB > BREATHE,68eca6a2-7c32-4bea-bcd1-c07dc50ee018,52.38,af8cdc87-789e-4bea-9d8b-927aa689d211,Not Rated,65.72,Not Rated,61.91,46.03,20.93
26.98,North West London Patient Index (NWL PI),1.1.7,HUB > DISCOVER NOW,6a390359-1e26-470f-a4e5-bfb31a5ed643,92.86,1fe1e7bb-ef6e-4d89-9824-bb560afc81f0,Silver,84.8,Silver,84.92,96.83,23.26
47.62,Systemic Anti-Cancer Treatment (SACT) data for CPRD GOLD,1.1.7,ALLIANCE > CPRD,6a8066c7-a8f4-44a6-9efd-871b19a3689f,47.62,014e7973-b43e-4a4a-91b4-de3f353b71b9,Not Rated,49.39,Not Rated,56.35,60.32,48.84
20.63,York Tissue Bank,1.1.7,ALLIANCE > TISSUE DIRECTORY,6aebcd6d-10c6-44cd-80d6-b5a90791db4f,71.43,71e898d1-db8c-4887-a605-dd6336b92a34,Bronze,75.25,Bronze,71.43,63.49,20.93
31.75,National Diabetes Audit - National Diabetes Foot Care Audit clinical dataset,1.1.7,ALLIANCE > HQIP,6b53f274-c927-4b8f-bcc3-1d85fabf16ee,26.19,dabf34b3-7368-4097-94c5-5b4f4be68fc6,Not Rated,47.98,Not Rated,45.23,22.22,30.23
22.22,Welsh Dispensing Dataset,1.1.7,ALLIANCE > SAIL,6b7893b5-74bc-49e2-ab4d-50e7695f54a5,92.86,50ef6443-ed4b-40f9-97fb-1cfd53be6579,Silver,85.97,Gold,88.09,98.41,20.93
23.81,Sheffield Brain Tissue Bank (SBTB),1.1.7,ALLIANCE > TISSUE DIRECTORY,6bc36f07-d55a-4a97-afab-29d93dc65bde,76.19,bdda7221-7c02-4ced-b7a8-3806a073d981,Bronze,75.31,Bronze,71.43,66.67,25.58
17.46,Leicester Respiratory Research Database,1.1.7,HUB > BREATHE,6bca5d27-5b98-45e7-b834-6980ba5db5c9,69.05,01c3d08c-6948-4059-a027-3437e4f5d53b,Bronze,75.22,Bronze,72.22,61.9,18.6
20.63,Leeds Breast Research Tissue Bank,1.1.7,ALLIANCE > TISSUE DIRECTORY,6bde3902-5d69-4c24-9d10-f84a63efdb22,69.05,2dc1218d-df5f-4025-826c-cf5ca7d67882,Bronze,74.06,Bronze,69.84,60.32,20.93
31.75,Covid-19 Second Generation Surveillance System,1.1.7,ALLIANCE > NHS DIGITAL,6c878d69-2662-42db-85da-15e087606442,76.19,fede31c6-a9c5-4cfb-9866-9b58b2199cff,Bronze,72.98,Silver,76.19,84.13,30.23
25.4,DARWIN1 Trial,1.1.7,ALLIANCE > TISSUE DIRECTORY,6ceec25d-2c8e-4dd7-8f99-2e56ec63c298,71.43,7f9672fa-dad5-479d-a929-52719e8cc2fa,Bronze,72.93,Bronze,69.05,63.49,25.58
33.33,National Joint Registry - Revision Elbow Replacement dataset,1.1.7,ALLIANCE > HQIP,6d1b9b23-1197-4857-9b17-9e26cb0633e8,26.19,12babf2b-42e8-4b1e-9143-3475a07bb343,Not Rated,46.81,Not Rated,44.45,22.22,32.56
36.51,Emergency Care Dataset (ECDS),1.1.7,ALLIANCE > BARTS HEALTH,6d41700e-6dac-47c1-ba31-eb2f23539efe,35.71,57fa56f2-78d1-49af-ab8d-e8146d711868,Not Rated,49.25,Not Rated,47.62,31.75,37.21
36.51,NHS Tayside and Fife Virology,1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,6dd0f10d-82fa-438f-ba74-9c880f60bf4c,21.43,855a84b2-9d58-4b2b-a450-b6c6d534e403,Not Rated,42.11,Not Rated,40.48,17.46,37.21
20.63,Wales Cancer Bank,1.1.7,ALLIANCE > TISSUE DIRECTORY,6dd6c679-7c5f-4d8e-b1e4-8f1447425e96,69.05,37886fb5-d0ae-400f-89eb-78664897bcf2,Bronze,74.06,Bronze,69.84,60.32,20.93
39.68,HES Outpatient data for CPRD Aurum,1.1.7,ALLIANCE > CPRD,6e1d8f50-f718-4964-9c88-2c80cbaa92b5,71.43,8d3f3e58-be79-4450-b2e3-f5ab8a25fb0e,Not Rated,65.95,Bronze,69.84,79.37,39.53
33.33,COVID19 Vaccination Adverse Reaction,1.1.7,ALLIANCE > NHS DIGITAL,6e20e516-97d4-4cdc-b41b-107ed3fc02f5,71.43,080a90e4-4bc6-4153-a4c6-c120eef5ba94,Bronze,69.44,Bronze,73.81,80.95,32.56
25.4,Biological samples,1.1.7,UK Biobank,6e5916d4-017c-4542-bc71-edf6d4c5a055,40.48,41ac38b0-31cd-4865-a357-80ce557b2312,Not Rated,56.28,Not Rated,55.55,36.51,27.91
34.92,"Trusted Research Environments for CVD-COVID-UK in England, Scotland and Wales",1.1.7,OTHER > BHF Data Science Centre,6ec3a47b-447a-4b22-9b7a-43acae5d408f,42.86,7e5f0247-f033-4f98-aed3-3d7422b9dc6d,Not Rated,53.99,Not Rated,50.8,36.51,34.88
31.75,Epilepsy 12 - Patient Reported Experience Measure,1.1.7,ALLIANCE > HQIP,6efbc62f-6ebb-4f18-959b-1ec6fd0cc6fb,26.19,cefa4d82-5a22-4c19-82ab-4663a364e49e,Not Rated,47.98,Not Rated,45.23,22.22,30.23
22.22,COVID-19 Test results,1.1.7,ALLIANCE > SAIL,6f24a4b8-66ab-4ea7-aa8c-3be3d0b4abf1,95.24,f5f6d882-163d-4ef1-a53e-000fba409480,Gold,87.16,Gold,88.89,100.0,20.93
31.75,Intensive Care National Audit and Research Centre,1.1.7,ALLIANCE > SAIL,6f348bdc-21e4-459b-b658-dc839a1e2133,83.33,fa8bf269-4769-491b-b398-fa63137d14ab,Silver,77.71,Silver,79.37,90.48,27.91
25.4,National Joint Registry - Primary Hip Replacement dataset,1.1.7,ALLIANCE > HQIP,7038a67d-34ca-4754-a50f-41aa2849db69,71.43,03280e87-6975-4a2a-967d-b332cb788e44,Bronze,72.93,Bronze,69.05,63.49,25.58
22.22,CASPS: A Phase II trial of Cediranib in ASPS patients,1.1.7,ALLIANCE > TISSUE DIRECTORY,70b4d407-288a-4945-a4d5-506d60715110,69.05,7dcd5c0a-1922-4fe2-9b7e-090e4c39861b,Bronze,72.89,Bronze,69.05,60.32,23.26
25.4,Avon Longitudinal Study of Parents and Children,1.1.7,ALLIANCE > AVON LONGITUDINAL STUDY OF PARENTS AND CHILDREN,71b8569c-b582-499c-85aa-909b825f6ea6,73.81,255d70c6-9a50-4b62-adc0-44216606a216,Bronze,74.12,Bronze,69.84,65.08,25.58
39.68,Infoflex Cancer Registry,1.1.7,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,72fe91de-b0c0-423a-ad68-bd7067b20ad8,16.67,5505e91d-9e0a-4969-87d5-00f256d91306,Not Rated,38.57,Not Rated,37.3,14.29,39.53
25.4,"Deeply-phenotyped hospital COVID patients: severity, acuity, therapies, outcomes",1.1.7,HUB > PIONEER,730b3e54-1f59-4c07-b5d6-e6b63e4dda35,78.57,16a09f1b-3654-4ec3-9913-fb70cb1e2364,Silver,76.5,Silver,80.16,85.71,25.58
17.46,UK BiLEVE Consortium Dataset,1.1.7,HUB > BREATHE,73462506-32c5-43a0-963e-06d67e967b97,78.57,b8bcda0b-3c90-4382-aeb7-b01fc27e58fa,Silver,81.14,Silver,76.19,69.84,16.28
20.63,"Prevention, detection, treatment: adult lung disease/cancer in rural Tamil Nadu",1.1.7,HUB > BREATHE,736a9d09-83c7-4cfa-ae82-a10b2a69efc8,61.9,2581994d-5be2-4465-bb62-60c4c97e8e2b,Bronze,71.65,Bronze,66.67,53.97,18.6
28.57,Annual District Death Daily,1.1.7,ALLIANCE > SAIL,73867034-fe12-4d23-8d11-66da716dcb3d,95.24,584bf8c8-d58f-44c6-9b65-e1611144fd54,Silver,85.99,Silver,85.72,100.0,23.26
31.75,COVID antigen testing - Pillar 1,1.1.7,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,7389dc03-1fc7-4af7-b12c-bbab448290f9,69.05,3abc20ce-3dc6-4715-9de0-56aa97a6f5ec,Bronze,68.25,Bronze,73.02,77.78,32.56
34.92,Labour Force Survey (Person),1.1.7,NCS > OFFICE FOR NATIONAL STATISTICS,73ba9de7-67fe-4728-b397-bc5fb1d67df1,30.95,8c60a308-1e47-4a0c-8b69-9259f05338cb,Not Rated,49.2,Not Rated,45.24,25.4,32.56
52.38,HIC Hepatitis v2,1.1.7,NIHR Health Informatics Collaborative Viral Hepatitis Theme,73f54071-62bf-48f5-8be1-569208b18ab8,95.24,66be725a-b950-4bf8-9a35-7e33ce765a25,Bronze,74.36,Bronze,73.81,100.0,46.51
20.63,Myeloma XII clinical trial samples,1.1.7,ALLIANCE > TISSUE DIRECTORY,74241b17-23b7-4233-b7b9-1a484aa053b0,69.05,576fbcf8-ff25-4230-ae69-e72ca02b95f1,Bronze,74.06,Bronze,69.84,60.32,20.93
20.63,Effects of second-hand smoke on pregnant women: a phenomenological study,1.1.7,HUB > BREATHE,7480abe4-e073-40ef-882d-217542b5e08e,66.67,4a5c610f-019d-450a-90c5-0fe315027f56,Bronze,74.03,Bronze,68.25,57.14,18.6
26.98,Cancer register,1.1.7,UK Biobank,75614b69-bc18-416b-9d27-fd8ca9fc4521,42.86,a4751434-54ea-4d22-a66a-a5d32bd80c40,Not Rated,56.31,Not Rated,55.56,38.1,30.23
39.68,CPRD GOLD,1.1.7,ALLIANCE > CPRD,756daeaa-6e47-4269-9df5-477c01cdd271,83.33,a29feafa-7bdd-44e9-b977-c9d26425e67f,Bronze,71.9,Bronze,75.4,90.48,39.53
31.75,Intensive Care National Audit and Research Centre - Covid19,1.1.7,ALLIANCE > SAIL,7639cdc3-f368-4a43-80bd-58a67e70d407,83.33,add6226b-0f21-439a-84a6-51dc26cdc425,Silver,77.71,Silver,79.37,90.48,27.91
36.51,National Asthma and COPD Audit Programme (NACAP): secondary care workstream – children and young people asthma (organisational),1.1.7,ALLIANCE > HQIP,76ec0282-02e0-4fff-b016-76bc6ffcb784,26.19,3efd9b30-1f84-48c0-a3e0-402ecb5c7724,Not Rated,45.66,Not Rated,42.86,22.22,34.88
22.22,The National COVID-19 Chest Imaging Database,1.1.7,NHSX,77824298-ef3b-40f7-a0a4-b6dedb2e7a02,95.24,31f0148b-f965-4136-ab39-6c5bbbf8c2d9,Gold,87.16,Gold,88.89,100.0,20.93
20.63,Leeds Multidisciplinary Research Tissue Bank,1.1.7,ALLIANCE > TISSUE DIRECTORY,7793f54e-73be-4c97-a941-ba105b1b0480,71.43,7e60a651-b3d6-40ef-93dc-1f87dabee7be,Bronze,75.25,Bronze,71.43,63.49,20.93
38.1,HES Admitted Patient Care data for CPRD GOLD,1.1.7,ALLIANCE > CPRD,77b5cf84-d4f2-4418-bafa-73306cf2d2b2,69.05,4bcf64a6-f404-4ef4-ae6e-172512ab5f43,Not Rated,65.92,Bronze,69.84,77.78,37.21
50.79,NHS Tayside and Fife Haematology Biochemistry (Lab Data Restructured),1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,7858978f-30e8-42e7-abe4-d9af5447c278,35.71,10ffac16-d0c2-4d53-ab6a-69a38e283223,Not Rated,44.6,Not Rated,47.62,46.03,46.51
20.63,UCL / UCLH Biobank for Studying Health and Disease,1.1.7,ALLIANCE > TISSUE DIRECTORY,7862c1c2-d4d6-4b3c-aea1-1f15a5b3b5ea,71.43,ce533c67-5565-4010-bedf-dca3863a9084,Bronze,75.25,Bronze,71.43,63.49,20.93
33.33,National Audit of Psychosis - Early Intervention Psychosis Audit patient experience survey,1.1.7,ALLIANCE > HQIP,78d25670-9d20-4eb7-a79a-f29e53cc981f,26.19,a464c126-8591-4af6-a10f-99c020f59527,Not Rated,46.81,Not Rated,44.45,22.22,32.56
55.56,Mental Health Minimum Dataset v4.1 (Sensitive) Episodes,1.1.7,ALLIANCE > NHS DIGITAL,78fe2e13-7f40-406f-a584-04909d0ce060,64.29,efecbe58-4822-4f17-bf5c-92113d143db9,Not Rated,56.57,Not Rated,61.11,77.78,51.16
28.57,EMEP4UK Pollution,1.1.7,HUB > BREATHE,79116473-bda2-413c-82ad-ba2b86e5076f,40.48,eb76598f-e228-413c-82f3-231809062611,Not Rated,57.45,Not Rated,53.18,34.92,25.58
34.92,National Cancer Registration and Analysis Service,1.1.7,PUBLIC HEALTH ENGLAND,79a7ad18-6941-4543-924a-787f2381f5e0,88.1,0a852454-ee67-443b-a091-d13499a71b41,Silver,77.77,Silver,78.57,92.06,32.56
22.22,Central England Haemato-oncology and oncology Research Biobank (CEHRB),1.1.7,ALLIANCE > TISSUE DIRECTORY,79b02690-798b-462d-9ced-f53c9e39d624,71.43,314953f6-58e7-49c0-adfd-c60e623eba74,Bronze,74.09,Bronze,70.64,63.49,23.26
55.56,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Records,1.1.7,ALLIANCE > NHS DIGITAL,7aa02796-787a-42c2-b97e-d008fa77e4b8,64.29,1a8fc23c-b67b-4171-b5e1-1b650fce1ef4,Not Rated,56.57,Not Rated,61.11,77.78,51.16
34.92,Moorfields AMD Dataset Release 002,1.1.7,HUB > INSIGHT,7aab11a7-6fff-4e4a-a480-b48ccc6bad87,73.81,bf392537-82b4-4d71-ace0-e7bea3b167fb,Bronze,69.47,Bronze,72.22,79.37,34.88
36.51,National Asthma and COPD Audit Programme (NACAP): Adult Asthma secondary care clinical dataset,1.1.7,ALLIANCE > HQIP,7dc319da-a16f-4e63-a115-0cba3905a322,26.19,becd2624-9a01-4f01-bcf8-56e94545a49a,Not Rated,45.66,Not Rated,42.86,22.22,34.88
33.33,Epilepsy 12 - National organisational audit (service descriptor questionnaire) and Trust profile,1.1.7,ALLIANCE > HQIP,7f125091-12ba-464d-af7d-9a88179b0b95,26.19,2c737d63-69f4-4a02-8df9-54c1e65e845f,Not Rated,46.81,Not Rated,44.45,22.22,32.56
30.16,UHB Eye Image Dataset Release 001,1.1.7,HUB > INSIGHT,7f4fb30c-2a09-4d75-bed2-114751e06723,88.1,21fb56d1-726f-40e3-a998-e4b34ba3e46f,Silver,80.09,Silver,82.54,95.24,27.91
33.33,"National Audit of Dementia - spotlight audit on the prescription of psychotropic medication, 2019",1.1.7,ALLIANCE > HQIP,7fab080b-6e2a-4c82-a5e5-daf99c70662a,26.19,949d9d7a-a3f1-480a-8563-3fb024300561,Not Rated,46.81,Not Rated,44.45,22.22,32.56
31.75,GENOMICS ENGLAND 100K CANCER & COMMON,1.1.7,GENOMICS ENGLAND,7fdb684d-bb7a-4d0b-8666-9f10510f071f,95.24,702f0198-bdfe-401e-97f2-35f5d26357ad,Silver,82.5,Silver,84.12,100.0,30.23
20.63,Developing Patient and Public Involvement in Research in Malaysia,1.1.7,HUB > BREATHE,7fe20f78-758d-4449-beb4-ccf98e2d8247,54.76,153c0ba6-f2ec-4fb4-b5a7-33e11cbdf7fc,Bronze,68.08,Not Rated,63.5,47.62,18.6
41.27,NHS Scotland General Practice (GP) Contact Data - Subset,1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,80b54fc9-8dc0-4134-880d-ffa8d4473204,71.43,8f486c3d-9504-4a0e-8e24-ab96f057fc9e,Bronze,69.44,Bronze,69.84,80.95,32.56
20.63,Cervical Screening Wales,1.1.7,ALLIANCE > SAIL,80e9c439-4909-4534-8bfe-6f01fdec7de7,95.24,b32325d7-7f00-4d20-9935-dd02e1bc6932,Gold,88.32,Gold,89.69,100.0,18.6
26.98,Risk and outcomes of coagulopathies in acutely unwell adults,1.1.7,HUB > PIONEER,81c54c5a-ceb1-487c-820a-437b4dd002ca,76.19,bf3fe16c-5377-4571-b5a5-7aa7e796594c,Bronze,74.14,Silver,78.57,84.13,27.91
55.56,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Episodes,1.1.7,ALLIANCE > NHS DIGITAL,8226b6fa-d815-4f15-9064-b56beb0fddb1,64.29,a27400b0-0efb-4af8-a7bc-e2c7e59796e3,Not Rated,56.57,Not Rated,61.11,77.78,51.16
25.4,Maternity Inpatient and Day Case - Scottish Morbidity Record (SMR02),1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,824e20d9-217a-4028-bb49-91164edcca00,83.33,d47c809f-3da8-4f8a-b1ee-258d21aad530,Silver,78.88,Silver,82.54,90.48,25.58
23.81,Research Donors Ltd,1.1.7,ALLIANCE > TISSUE DIRECTORY,826114ca-2563-4c0c-b023-3417ead32956,76.19,fcb62cb3-c876-47a3-961e-fb27c6f718fa,Bronze,75.31,Bronze,71.43,66.67,25.58
31.75,National Audit of Dementia Round 4 - staff questionnaire,1.1.7,ALLIANCE > HQIP,82665c1e-df7f-4136-a05f-0826533149e5,26.19,ef6e68d6-dcba-410c-943c-26ca21376a3a,Not Rated,47.98,Not Rated,45.23,22.22,30.23
20.63,National Exercise Referral Scheme,1.1.7,ALLIANCE > SAIL,8270e26b-65ea-479c-8462-f5315b2657eb,95.24,131784c0-769d-4f7b-b7d0-b5f4b89886d4,Gold,88.32,Gold,89.69,100.0,18.6
20.63,Northern Ireland Biobank (NIB),1.1.7,ALLIANCE > TISSUE DIRECTORY,82f4cf19-9e6a-4c31-8cc3-085f3d44ba44,71.43,c6e1ea88-f5bf-4a57-953f-688f313fcb04,Bronze,75.25,Bronze,71.43,63.49,20.93
47.62,HIC Acute Coronary Syndromes,1.1.7,NIHR Health Informatics Collaborative Cardiovascular Theme,844f3be0-f50d-4a88-9783-0928ad1c2aad,95.24,869a9b4e-3537-449f-9a59-a0eac523c4e4,Bronze,75.53,Silver,76.19,100.0,44.19
20.63,"Oncology Clinical Trials Office, University of Oxford",1.1.7,ALLIANCE > TISSUE DIRECTORY,8466ec6f-8a4c-4286-8138-04c35e12b1f8,69.05,4a65f6d6-f2e4-4d98-a3a4-94a32206836d,Bronze,74.06,Bronze,69.84,60.32,20.93
23.81,COMPARE,1.1.7,OTHER > The University of Cambridge,84b6d047-2a05-4fc0-8537-809dbb3d18ed,45.24,8cbb73e2-a2c4-4caf-8dcd-6ac3795bb996,Not Rated,59.83,Not Rated,57.94,39.68,25.58
39.68,CRIS,1.1.7,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,84de0d13-f5bd-4c22-83d3-e1adb00d5a72,16.67,67cea834-33f5-4ed7-9dc2-072ad077de07,Not Rated,38.57,Not Rated,37.3,14.29,39.53
28.57,North West London Coordinate My Care (NWL CMC),1.1.7,HUB > DISCOVER NOW,850f99cb-f091-4f10-86ee-06a3eaa7df53,92.86,c853b41b-fbd1-4896-b0fb-85303109fec4,Silver,83.64,Silver,84.13,96.83,25.58
47.62,Cancer registration data for CPRD Aurum,1.1.7,ALLIANCE > CPRD,851bb11b-fa75-44ee-afe9-948dc7652555,47.62,3f3df3be-05a8-42b2-89d9-f731deb7ea66,Not Rated,49.39,Not Rated,56.35,60.32,48.84
31.75,National Diabetes Audit - National Diabetes in Pregnancy clinical Audit dataset,1.1.7,ALLIANCE > HQIP,858c517e-8ce3-4059-9326-d158489e48d1,26.19,7c789df2-46f0-4e0e-b6ff-b04dce801445,Not Rated,47.98,Not Rated,45.23,22.22,30.23
39.68,HES Outpatient data for CPRD GOLD,1.1.7,ALLIANCE > CPRD,8625eb42-93df-4d33-875b-e6a93413d7ba,71.43,21dc2345-3983-4a46-960c-f17974bc7b71,Not Rated,65.95,Bronze,69.84,79.37,39.53
36.51,Cystic Fibrosis Patient Tendon Rupture,1.1.7,ALLIANCE > CYSTIC FIBROSIS TRUST,8638e095-a609-463f-b36e-c4cac4519660,95.24,4fcc8b11-2b9b-4f68-b51a-978749d89acc,Silver,83.66,Silver,81.75,100.0,27.91
22.22,Oxford Musculoskeletal Biobank,1.1.7,ALLIANCE > TISSUE DIRECTORY,865f0e79-f862-493b-b863-b39b777d60ca,69.05,ccd6e59d-3582-4f47-a4cd-f5845192d75c,Bronze,72.89,Bronze,69.05,60.32,23.26
14.29,Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS),1.1.7,HUB > BREATHE,8665b36e-f9a5-4062-ba56-d33fecfe3376,78.57,cc6f926a-90cf-4083-84e7-131d1e63813b,Silver,82.31,Silver,76.98,68.25,13.95
47.62,HES:Civil Registration (Deaths) bridge,1.1.7,ALLIANCE > NHS DIGITAL,86d7088b-7a15-4e9a-b2b0-857a67e04650,64.29,21aec912-444f-447d-b3c4-6791a6c82667,Not Rated,60.05,Not Rated,64.28,76.19,44.19
42.86,Death Registration data for CPRD GOLD,1.1.7,ALLIANCE > CPRD,87244819-4596-4e5d-baaa-f3fe4eb74b4b,69.05,1d35e229-13eb-4be1-9dae-4752b6c27c4a,Not Rated,63.59,Bronze,67.46,77.78,41.86
34.92,National Early Inflammatory Arthritis Audit - clinical dataset,1.1.7,ALLIANCE > HQIP,875999d5-f5ed-4136-ac20-b20f1abe27dd,26.19,b0797c05-352f-455f-8d27-150b6f6354cc,Not Rated,46.81,Not Rated,43.65,22.22,32.56
20.63,University of Southampton Faculty of Medicine Tissue Bank,1.1.7,ALLIANCE > TISSUE DIRECTORY,88576066-fb5f-43e2-8af4-0904630b2f1b,69.05,786563e9-5377-4d18-8d32-65ff14d53987,Bronze,74.06,Bronze,69.84,60.32,20.93
55.56,Mental Health Minimum Dataset v2.6 (Non-Sensitive),1.1.7,ALLIANCE > NHS DIGITAL,895e5c2f-e484-4d08-91c6-35ac2f85c231,64.29,702201ff-e729-4e29-a428-32953c9a0332,Not Rated,56.57,Not Rated,61.11,77.78,51.16
20.63,Human Biomaterials Resource Centre,1.1.7,ALLIANCE > TISSUE DIRECTORY,89aac17d-f8a1-4ddc-9495-4adc278234a9,69.05,2f085ac6-d33d-4b9b-8a99-624cc51c3f17,Bronze,74.06,Bronze,69.84,60.32,20.93
34.92,Hospital Episode Statistics Outpatients,1.1.7,ALLIANCE > NHS DIGITAL,8a05b76d-b0ec-4c28-96b5-11601e26933a,78.57,d4362d41-0838-4f41-bba3-c3268312c444,Bronze,71.84,Bronze,75.39,85.71,34.88
36.51,Fife Radiology,1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,8a128e75-0188-40a3-94d4-5f1967fcffb2,21.43,d020302b-a691-49fb-9d10-1274af2f3110,Not Rated,42.11,Not Rated,40.48,17.46,37.21
42.86,Patient postcode linked deprivation measures for CPRD Aurum,1.1.7,ALLIANCE > CPRD,8ab1dc13-634e-46ae-9ba0-e094d446bd74,50.0,bd85a09c-fe4a-41b8-81d2-77feadcd1a0a,Not Rated,51.75,Not Rated,60.31,63.49,46.51
34.92,NIHR BioResource: Demographic,1.1.7,ALLIANCE > NIHR BIORESOURCE,8c573599-30cf-4708-bcbd-e2e37c795664,78.57,d2c486bb-b95b-4093-bb58-b196cfc08c7b,Bronze,73.0,Bronze,75.39,85.71,32.56
41.27,Sectra PACS,1.1.7,ALLIANCE > BARTS HEALTH,8c7abca7-4292-4d1f-b311-c132a7adf109,19.05,10bf4c08-6702-44fe-8faa-1280dea6b0c9,Not Rated,38.59,Not Rated,37.3,15.87,41.86
17.46,Child Health Systems Programme - 6-8week review,1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,8cfbaeec-98ce-4e09-b49c-d7c5968f1e85,76.19,f9cf4be7-fbc9-4601-8beb-5d3c3596bf04,Silver,79.95,Silver,82.54,82.54,16.28
49.21,Bridge file: Hospital Episode Statistics to Mental Health Minimum Data Set,1.1.7,ALLIANCE > NHS DIGITAL,8d3f80d4-aeae-46f0-809b-cd6c51e24f75,64.29,31bb8022-f8b1-405a-a22f-140f7c4b4fa6,Not Rated,58.89,Not Rated,64.28,77.78,46.51
39.68,REal-time Assessment of Community Transmission (REACT-2),1.1.7,ALLIANCE > IMPERIAL COLLEGE LONDON,8e5e3ebe-c0ae-458f-bc75-a5a3368d4c2d,61.9,25003f25-384c-4264-9c8f-dd8734ee5595,Not Rated,63.51,Not Rated,65.08,69.84,34.88
31.75,Community Services Data Set,1.1.7,ALLIANCE > NHS DIGITAL,8e66e623-2859-4a65-93d7-abd41e139976,52.38,5616e0a6-22f1-43a5-a2bd-dcecfa2f3b70,Not Rated,59.91,Not Rated,65.87,63.49,32.56
22.22,Outpatient Dataset,1.1.7,ALLIANCE > SAIL,8e6d7fcc-a4ad-4a32-bbc2-fe8631a38b43,95.24,d331159b-b286-4ab9-8b36-db39123ec229,Gold,87.16,Gold,88.89,100.0,20.93
36.51,Mental Health Services Data Set - Inpatients,1.1.7,ALLIANCE > NHS DIGITAL,8eace3c2-1dc8-4708-9350-ad129b7d2bc9,47.62,275ac6a4-798b-4f49-a25e-008245050bbc,Not Rated,54.05,Not Rated,54.76,46.03,39.53
26.98,The impact of hospitalised patients with COPD: from admission to outcome,1.1.7,HUB > PIONEER,8fac682b-96be-4e21-a2a9-5fe66c3b35ff,76.19,780bf7d0-9ee1-4641-a74f-dc148e361970,Bronze,74.14,Silver,78.57,84.13,27.91
17.46,Pneumonia case management practices in selected communities in Pakistan,1.1.7,HUB > BREATHE,8fc0a2cc-a8ce-4558-a98a-c514255833d8,69.05,cf190350-74c6-45f2-8ede-69ace62eb88d,Silver,77.55,Bronze,70.63,58.73,13.95
38.1,Covid-19 Infection Survey,1.1.7,NCS > OFFICE FOR NATIONAL STATISTICS,90ad6023-6c7f-4605-9323-b478a27c3c9a,73.81,628e9ad9-28c5-4d58-9ec5-04a63be9b4cf,Bronze,69.47,Bronze,71.42,80.95,34.88
20.63,Bloodwise Childhood Leukaemia Cell Bank,1.1.7,ALLIANCE > TISSUE DIRECTORY,914321d0-1d86-4974-a38d-97469f9ff2cd,71.43,93baeb13-cc4b-47fd-9dae-5ae5277cba54,Bronze,75.25,Bronze,71.43,63.49,20.93
36.51,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - organisational audit,1.1.7,ALLIANCE > HQIP,91479cbf-664e-4782-8514-a3247bb5c4f4,26.19,4b33fc6d-3cac-4404-adac-d693328456fa,Not Rated,45.66,Not Rated,42.86,22.22,34.88
31.75,National Records of Scotland (NRS) - Stillbirth Data,1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,92490df7-466b-4cd8-af4f-4528ed21d203,85.71,dca0c95b-ae7d-4163-8c3b-a881f779df02,Silver,80.06,Silver,80.16,92.06,25.58
31.75,National Diabetes Audit - Core Clinical Audit Dataset,1.1.7,ALLIANCE > HQIP,92d95f82-50a5-4df9-914a-ca26b14cf84c,26.19,f4c8900b-5db5-4426-95e9-2f1617c92a76,Not Rated,47.98,Not Rated,45.23,22.22,30.23
34.92,Yorkshire Specialist Register of Cancer in Children and Young People,1.1.7,HUB > DATA-CAN,931efe47-04eb-4ff3-aa62-97e2e4007aed,92.86,93582beb-e45a-47b6-aeab-d26f583e4c3b,Silver,82.47,Silver,80.95,96.83,27.91
26.98,National Survey for Wales,1.1.7,ALLIANCE > SAIL,9360bc6c-2a7d-4415-869d-3e853c558f4d,95.24,bcca421a-9077-4c47-9daa-b1bc030d3dee,Silver,85.99,Gold,86.51,100.0,23.26
50.79,Demography,1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,93ad5a26-65f5-438f-b4e3-9f7078cc2f92,35.71,b88c2b24-b75d-4d28-9391-2dbac1605a17,Not Rated,44.6,Not Rated,47.62,46.03,46.51
25.4,Imaging,1.1.7,UK Biobank,93d26255-7199-4ea7-997d-f74890d12b87,38.1,32a2dcb1-1e18-44ba-ad49-b3da312ca447,Not Rated,55.09,Not Rated,54.76,34.92,27.91
22.22,National Unified Renal Translational Research Enterprise (NURTuRE),1.1.7,ALLIANCE > TISSUE DIRECTORY,9445e723-655a-43d0-a4e5-50313d98eac0,69.05,15f07cef-f4cc-4a50-90bc-9fd40f8b6327,Bronze,72.89,Bronze,69.05,60.32,23.26
20.63,BioDock,1.1.7,ALLIANCE > TISSUE DIRECTORY,94e28efd-a976-4748-81fd-956a598c26cb,69.05,ecb82441-286f-408d-880c-9239a25fb5cd,Bronze,74.06,Bronze,69.84,60.32,20.93
20.63,RAPPER,1.1.7,ALLIANCE > TISSUE DIRECTORY,94fab6d3-9753-4ffd-ade2-02d199d93f94,71.43,76d26f0f-0136-4ae5-8be9-37782a70bac5,Bronze,75.25,Bronze,71.43,63.49,20.93
52.38,Mental Health Dataset (MHDS) for CPRD GOLD,1.1.7,ALLIANCE > CPRD,95475a1f-1623-4bfa-9821-1159d4dbcc8e,50.0,d5c0cc93-3347-46f0-b8dd-f44e82718e38,Not Rated,49.42,Not Rated,55.55,63.49,51.16
34.92,VIVALDI 2,1.1.7,OTHER > UNIVERSITY COLLEGE LONDON,96c73136-da1b-43de-9fd1-9d5e63631b14,59.52,12f1ffbc-0ddd-4d6e-b126-2cccf6738658,Not Rated,63.48,Bronze,67.46,69.84,32.56
47.62,Pregnancy Register for CPRD GOLD,1.1.7,ALLIANCE > CPRD,96d29a1d-9566-4793-8dbb-351fbe2eb790,54.76,14aaf184-5922-4459-affb-6c9e55c12176,Not Rated,52.96,Not Rated,61.11,69.84,48.84
28.57,SAIL Dementia e-Cohort,1.1.7,ALLIANCE > SAIL,9709ee81-c5f1-4c01-a1ac-51ae2a0a60f3,83.33,f48b7c05-6a44-480c-84c6-4f7a684f29f8,Silver,77.71,Silver,80.96,90.48,27.91
55.56,Mental Health Minimum Dataset v4 (Sensitive) Records,1.1.7,ALLIANCE > NHS DIGITAL,97fa09e6-5ea5-41cd-baf8-20366db13a3f,64.29,eab996ed-b268-439a-bff4-19925698336a,Not Rated,56.57,Not Rated,61.11,77.78,51.16
44.44,Quality of Life of Cancer Survivors in England: Pilot Patient Reported Outcomes Measures Survey (2011) for CPRD GOLD,1.1.7,ALLIANCE > CPRD,992c8fe6-f460-490c-b202-8d4d9c434425,47.62,4b1da116-44a5-4952-a09e-deb0d37af2f2,Not Rated,49.39,Not Rated,57.94,60.32,48.84
22.22,RATHL Trial,1.1.7,ALLIANCE > TISSUE DIRECTORY,99812cec-ea1c-4979-8e00-32df5bad000b,73.81,e5ec63dd-4da5-4119-99c8-5cc79045618c,Bronze,75.28,Bronze,70.64,63.49,23.26
33.33,National Bowel Cancer Audit - clinical dataset,1.1.7,ALLIANCE > HQIP,9a4ef776-6b4b-40cd-9c88-cbf1128780e9,26.19,c8a28f0b-a5f8-4dbb-8d71-5b89c7cb3111,Not Rated,46.81,Not Rated,44.45,22.22,32.56
42.86,Cancer Patient Experience Survey (CPES) for CPRD GOLD,1.1.7,ALLIANCE > CPRD,9a58219f-8cea-479c-bb5f-c68cae23136b,47.62,a4ecb8df-c72f-4018-8f23-e180c28dfdb6,Not Rated,50.55,Not Rated,58.73,60.32,46.51
28.57,COVID-19 Clinical Information Network (CO-CIN),1.1.7,ALLIANCE > ISARIC 4C,9a85b69e-fd3e-4522-bc68-48024df0ea3e,80.95,84336be3-23bd-466e-b29b-df48db897665,Silver,78.84,Silver,78.57,85.71,23.26
34.92,Coronavirus and the social impacts on Great Britain,1.1.7,NCS > OFFICE FOR NATIONAL STATISTICS,9ad4cc56-e86f-4d96-a515-05ee37edc1e9,78.57,e253257c-48c2-491b-b3b9-205161a16a7e,Bronze,74.17,Bronze,74.6,84.13,30.23
36.51,Mental Health Services Data Set - Currencies,1.1.7,ALLIANCE > NHS DIGITAL,9b7f7994-0b9c-4809-b67d-45ae1f04ec5c,47.62,add485fa-4c54-4a3e-8676-abe2ff4725a5,Not Rated,54.05,Not Rated,54.76,46.03,39.53
41.27,HES Patient Reported Outcomes Measures (PROMs) data for CPRD GOLD,1.1.7,ALLIANCE > CPRD,9bc66d1b-68a2-4d4e-a54a-cc3842ff95c7,61.9,2439a88e-d961-4152-a7b5-042097946209,Not Rated,61.19,Not Rated,65.08,71.43,39.53
38.1,National Asthma and COPD Audit Programme (NACAP):COPD and adult asthma secondary care organisational dataset,1.1.7,ALLIANCE > HQIP,9beca627-12cd-4231-8638-93cf0bdfa413,23.81,1982d9ef-890a-41ff-a86a-de61d65aaa09,Not Rated,43.3,Not Rated,41.27,20.63,37.21
36.51,PHM and Cancer Outcomes in the WYH Cancer Alliance,1.1.7,HUB > DATA-CAN,9bfba8a4-43c3-4356-93a5-3eb3b7bc247a,78.57,bc839e9c-e303-4c3c-9c2c-9975602376e2,Bronze,71.84,Bronze,74.6,85.71,34.88
36.51,Falls and Fragility Fracture Audit Programme National Hip Database clinical dataset,1.1.7,ALLIANCE > HQIP,9c0f13ca-5831-4d9b-860a-7d856be7a9f1,26.19,e06b951b-e9d8-4a2c-a51f-1d819f669205,Not Rated,45.66,Not Rated,42.86,22.22,34.88
23.81,"Extended Cohort for E-health, Environment and DNA (EXCEED)",1.1.7,HUB > BREATHE,9ca6e8d2-98d2-4757-84e1-287585400e55,95.24,e22ddf52-7f9e-4072-ae61-cb722461b37d,Gold,87.16,Gold,88.09,100.0,20.93
36.51,Tayside Pathology,1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,9ce35921-a1de-444b-a822-c0f6a8003797,21.43,419e5a82-2d82-48a7-a8f3-a83e64a54e92,Not Rated,42.11,Not Rated,40.48,17.46,37.21
28.57,IBD NIHR BioResource: Sample holding,1.1.7,HUB > GUT REACTION,9d4f445e-f81e-45d7-bd83-7e9f68199b4f,90.48,f2af20f9-af84-40ce-8a07-7d095948653e,Silver,82.45,Silver,83.34,95.24,25.58
34.92,National Early Inflammatory Arthritis Audit - patient survey,1.1.7,ALLIANCE > HQIP,a05443cd-e292-4b5f-b1f1-95718e300d46,26.19,e87410ec-a819-43db-99d1-f887c977e525,Not Rated,46.81,Not Rated,43.65,22.22,32.56
20.63,UK CLL Trials Biobank,1.1.7,ALLIANCE > TISSUE DIRECTORY,a06afa88-caba-4354-ac70-d05c67b34dfc,69.05,636e216a-072b-4c8b-b867-23b7666d2cb2,Bronze,74.06,Bronze,69.84,60.32,20.93
49.21,Cancer registration data for CPRD GOLD,1.1.7,ALLIANCE > CPRD,a0dad23c-c02d-4347-92ef-0019fa59eb3e,50.0,e2f5d637-94b3-447b-b7eb-ea957ce449b6,Not Rated,49.42,Not Rated,56.34,61.9,51.16
58.73,HIC Transplantation,1.1.7,NIHR Health Informatics Collaborative Renal Transplantation Theme,a0e0c0c2-072a-47ac-9252-e27b37ac024f,92.86,359a322e-3781-4796-b6b2-81962fa19b7a,Bronze,70.85,Bronze,69.84,98.41,51.16
25.4,Biological sample assays,1.1.7,UK Biobank,a11a234b-8b59-41e8-920a-f8f1799d3c77,38.1,14c697a5-2d41-4d86-bf17-2e596d07418b,Not Rated,55.09,Not Rated,54.76,34.92,27.91
39.68,NIHR BioResource: Case report form,1.1.7,ALLIANCE > NIHR BIORESOURCE,a182b27f-5000-40f0-8afd-f2f193a31b7d,78.57,4b8675d3-dd87-4cca-804c-aaf0e4ff8140,Bronze,71.84,Bronze,73.02,85.71,34.88
55.56,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Events,1.1.7,ALLIANCE > NHS DIGITAL,a1a67182-e81b-4144-ac51-92a86f277eb2,64.29,7b31b427-b447-432e-9a6c-ad2099343491,Not Rated,56.57,Not Rated,61.11,77.78,51.16
20.63,Brecon dataset,1.1.7,ALLIANCE > SAIL,a1e1ec62-d78c-40ac-9f90-66ef1dd865b2,95.24,9c6e891f-6449-48d2-a1c3-8dd236e34bbd,Gold,88.32,Gold,89.69,100.0,18.6
38.1,Death registration data - Provisional Monthly Extracts,1.1.7,NCS > OFFICE FOR NATIONAL STATISTICS,a28cf3ca-8bad-45bb-bca0-78b4d22fed69,73.81,487222b7-5c13-4a92-8b41-044796048720,Bronze,69.47,Bronze,71.42,80.95,34.88
28.57,Comprehensive Patient Records for Cancer Outcomes,1.1.7,HUB > DATA-CAN,a337845e-1dde-445b-90cf-91d8b825e3a5,95.24,ce4582a8-0985-46c6-b95f-29a5de862d4a,Silver,85.99,Silver,85.72,100.0,23.26
41.27,ECOSS (-/+VE tested patients only),1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,a3b9cfd3-abd1-4d18-99cc-360cd9d543c2,76.19,5542cadc-11a4-4957-bbdd-8a6c46bcfb87,Bronze,71.81,Bronze,71.43,84.13,32.56
20.63,Care Home Dataset,1.1.7,ALLIANCE > SAIL,a45acd02-82d7-4bfe-9845-6b4df683bba8,95.24,aae02f9e-1bad-415d-9730-c46a07a990aa,Gold,88.32,Gold,89.69,100.0,18.6
20.63,UK ME/CFS Biobank,1.1.7,ALLIANCE > TISSUE DIRECTORY,a5163bce-7c03-4e61-8ebc-024939c047a8,71.43,d0694e15-b6ba-4a95-962a-dbf627ca207c,Bronze,75.25,Bronze,71.43,63.49,20.93
34.92,The Primary-Secondary Care Partnership to Improve Outcomes in Chronic Kidney Disease,1.1.7,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,a5c088cd-dae6-4c58-b381-a0d273585f4d,28.57,d472a895-8587-4503-956e-3bd66d990979,Not Rated,46.84,Not Rated,44.45,23.81,34.88
36.51,Sars-CoV-2 Immunity & REinfection EvaluatioN (SIREN),1.1.7,ALLIANCE > PUBLIC HEALTH ENGLAND,a638f8a0-3527-49a8-a269-06db49f051c6,59.52,8e0221d4-dcfa-4580-834b-f44421fca3b5,Not Rated,63.48,Not Rated,65.87,68.25,32.56
22.22,plasmaMATCH,1.1.7,ALLIANCE > TISSUE DIRECTORY,a6472a29-17db-477c-bb6e-264686c8fc26,69.05,5618f65d-23fc-4bd5-9a4c-73e4b330c3a6,Bronze,72.89,Bronze,69.05,60.32,23.26
39.68,LIMS,1.1.7,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,a74f72ad-bf70-42e4-8933-069c7b53c7f9,16.67,df70b490-3c00-458e-a6dd-ea3242a3ebac,Not Rated,38.57,Not Rated,37.3,14.29,39.53
49.21,Quality of Life of Colorectal Cancer Survivors in England: Patient Reported Outcome Measures Survey for CPRD Aurum,1.1.7,ALLIANCE > CPRD,a772b8dd-cb93-4f27-a349-329992e0b212,50.0,c84192af-a477-4ed5-a95b-c88e1f98ce1b,Not Rated,49.42,Not Rated,57.14,63.49,51.16
22.22,GP dataset - Welsh Primary Care,1.1.7,ALLIANCE > SAIL,a79dbdef-eac1-49d7-9fdb-150ed5340481,95.24,33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2,Gold,87.16,Gold,88.89,100.0,20.93
28.57,HDR UK Papers & Preprints,1.1.7,OTHER > HEALTH DATA RESEARCH UK,a7ddefbd-31d9-4703-a738-256e4689f76a,95.24,fd8d0743-344a-4758-bb97-f8ad84a37357,Gold,87.16,Silver,85.72,100.0,20.93
12.7,Scottish Immunisation Recall System (SIRS),1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,a807ff6d-bdcd-4649-a9d2-b7bc6dfb9a5b,61.9,c027d0ca-7c7d-4864-b4dd-8040f4020fbb,Bronze,75.14,Bronze,70.63,53.97,11.63
36.51,National Asthma and COPD Audit Programme (NACAP): primary care workstream resources,1.1.7,ALLIANCE > HQIP,a895be78-f41c-40b8-b2fa-678a071a6427,26.19,8a3ec96a-0600-4c6d-8761-9d277f07b9da,Not Rated,45.66,Not Rated,42.86,22.22,34.88
25.4,Salford Lung Study,1.1.7,HUB > BREATHE,a8f5117e-7523-452f-abf3-ced72f03cb2e,61.9,86838cad-d5d3-4b65-9c37-29b0c8c36309,Bronze,68.16,Not Rated,65.08,55.56,25.58
23.81,Scottish Cancer Registry (SMR06),1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,a971ac7b-04e5-4bd5-8bfa-b456d5ed4dbf,83.33,ad36dc03-1856-44de-99b0-1af6f312d86b,Silver,80.03,Silver,83.34,90.48,23.26
26.98,"Demography, interventions & outcomes of patients with Cerebrovascular Disease",1.1.7,HUB > PIONEER,a9b50e33-9974-4635-8e52-9c9b3cb87eb2,73.81,ddf7f82f-b453-442d-b562-bb0157593831,Bronze,72.95,Silver,77.78,82.54,27.91
28.57,North West London Primary Care Events Data (NWL PCE),1.1.7,HUB > DISCOVER NOW,a9f4a852-a1f2-4041-bb33-3a50e6c43f8d,92.86,0f930154-0a0e-4bef-9464-59e657b904d6,Silver,83.64,Silver,84.13,96.83,25.58
55.56,Mental Health Minimum Dataset v3_3.5 (Non-Sensitive),1.1.7,ALLIANCE > NHS DIGITAL,aa019da2-0f2f-493c-95e8-7263ee735f46,64.29,348b12fb-7718-477e-a572-4fc3c716152d,Not Rated,56.57,Not Rated,61.11,77.78,51.16
36.51,Fife Microbiology: Tests,1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,aa5c8e81-ad02-4366-9577-472f7ed339d9,21.43,0c43c0b6-de3a-478b-8190-4da37fbe5ff5,Not Rated,42.11,Not Rated,40.48,17.46,37.21
38.1,HES Diagnostic Imaging Dataset for CPRD GOLD,1.1.7,ALLIANCE > CPRD,aa8c53e8-f91f-41f7-9522-7e2462a9a84b,69.05,a1bef3a6-9700-43a5-8f3e-dad44ce1fe10,Not Rated,65.92,Bronze,69.84,77.78,37.21
46.03,Mental Health Minimum Data Set,1.1.7,ALLIANCE > NHS DIGITAL,acafb160-b18a-436e-90f1-dc4530a90267,61.9,285ae0ae-196b-4a75-b1f1-78b07162acfa,Not Rated,57.7,Not Rated,64.28,74.6,46.51
26.98,Covid Immunisation,1.1.7,NCS > OFFICE FOR NATIONAL STATISTICS,acd433ab-51a7-445b-8700-fbce57d82a29,42.86,e1a6c1e1-1cec-49cd-aea0-37d4ff56435d,Not Rated,58.64,Not Rated,54.77,36.51,25.58
28.57,IBD NIHR BioResource: Contact detail,1.1.7,HUB > GUT REACTION,ad638da8-366b-481f-995e-fc326301eb16,88.1,02ddc5c9-03d4-40e4-9934-e60817ec8f3e,Silver,81.26,Silver,81.75,92.06,25.58
20.63,Cardiff School of Dentistry Tooth Bank,1.1.7,ALLIANCE > TISSUE DIRECTORY,adbee090-9634-455e-9be1-62843158fb08,69.05,0d4f0103-82d8-43f4-8058-4aec80ea562f,Bronze,74.06,Bronze,69.84,60.32,20.93
28.57,North West London Admitted Patient Care Data (NWL APC),1.1.7,HUB > DISCOVER NOW,adce90ad-d576-4c98-9de9-dca19f7f4d41,92.86,788857b5-6a5b-4ec2-825e-d965e291cf45,Silver,83.64,Silver,84.13,96.83,25.58
20.63,Biobank for patients with retinal degenerations & dystrophies,1.1.7,ALLIANCE > TISSUE DIRECTORY,ae2022bc-2083-4e57-b825-1fb610d910ee,69.05,cee932f8-151c-4834-ac6d-61d842f9d170,Bronze,74.06,Bronze,69.84,60.32,20.93
25.4,Optimum Patient Care Research Database,1.1.7,HUB > BREATHE,ae4b8371-d037-46e8-bdcd-bf3de08ef38e,50.0,e3ca35c1-b2e2-4479-adf1-6a78b1c8c088,Not Rated,63.37,Not Rated,57.94,41.27,23.26
36.51,Cystic Fibrosis Patient NTM culture,1.1.7,ALLIANCE > CYSTIC FIBROSIS TRUST,ae788191-69e5-4a03-b11b-bd25574b0e4f,95.24,69bdac5f-bb70-4ca5-a5ce-51a6106ad00b,Silver,83.66,Silver,81.75,100.0,27.91
41.27,Community Services Dataset,1.1.7,ALLIANCE > BARTS HEALTH,ae9e8a9f-533f-4823-8e00-84e39ad2c266,19.05,cae0a9a5-1bf2-49c3-b8d1-c315d3239074,Not Rated,38.59,Not Rated,37.3,15.87,41.86
31.75,National Audit of Care at the End of Life - Quality Survey,1.1.7,ALLIANCE > HQIP,aeb2f1ea-c914-4b30-94c8-9fd3eb51b288,26.19,51a8dfba-5c94-48bd-9c68-3707f0ebc2a2,Not Rated,47.98,Not Rated,45.23,22.22,30.23
20.63,Community perception on public health measures for COVID-19 prevention/control,1.1.7,HUB > BREATHE,af238430-c257-4d60-9ff0-1de6b825f09e,64.29,6464fb4f-2838-495b-9963-4001204ed166,Bronze,72.84,Bronze,67.47,55.56,18.6
20.63,Manchester Cancer Research Centre (MCRC) Biobank,1.1.7,ALLIANCE > TISSUE DIRECTORY,af2b3e6d-718e-464a-8c0d-5882fa1d869f,71.43,095d805c-4b62-4726-b968-bb2f1c463701,Bronze,75.25,Bronze,71.43,63.49,20.93
20.63,Cardiff University Biobank,1.1.7,ALLIANCE > TISSUE DIRECTORY,af2ecff2-398c-437f-8c45-adef2406ce43,71.43,097540aa-a0ed-492e-853b-9ebcfd061dea,Bronze,75.25,Bronze,71.43,63.49,20.93
20.63,NIHR Exeter Clinical Research Facility,1.1.7,ALLIANCE > TISSUE DIRECTORY,af4af5cc-a9eb-4e0e-b50a-3cab4ac2daf9,69.05,df9b7bb1-1b26-4e67-b885-df2dcb8e3450,Bronze,74.06,Bronze,69.84,60.32,20.93
22.22,National Neonatal Research Database,1.1.7,ALLIANCE > NEONATAL DATA ANALYSIS UNIT - IMPERIAL COLLEGE LONDON,afc8af43-d6cd-4faa-b204-8fc471119b98,90.48,67020745-9def-4c6e-b5ac-bb273bd0a20e,Silver,85.94,Gold,86.51,95.24,18.6
38.1,Tayside Radiology,1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,b1dc1917-8522-4ecd-a829-c866c5cffe3b,21.43,af10ec29-1866-4726-b33f-3948afe182f2,Not Rated,40.95,Not Rated,39.68,17.46,39.53
25.4,Primary-care data,1.1.7,UK Biobank,b27afede-a51d-4aae-8bf7-ce94888fe898,38.1,439e71c7-33b5-4e85-98ce-4b068f2523ad,Not Rated,55.09,Not Rated,54.76,34.92,27.91
36.51,Cystic Fibrosis Patient Transplants,1.1.7,ALLIANCE > CYSTIC FIBROSIS TRUST,b2fb79c5-26db-484b-8e93-1c56d7654f57,95.24,bea354e8-c552-41ef-80c2-a76ca5767e4b,Silver,83.66,Silver,81.75,100.0,27.91
52.38,HIC ICU 8.3.2,1.1.7,NIHR Health Informatics Collaborative Critical Care Theme,b40777a2-468b-4b45-8b7d-2f62f912e950,95.24,4f546f1e-433c-4884-a090-2a4520c878ac,Bronze,74.36,Bronze,73.81,100.0,46.51
36.51,UK Cystic Fibrosis Registry (CYFI),1.1.7,ALLIANCE > SAIL,b43309eb-7860-49b7-9f11-1a7a0fd5532e,80.95,0628fb77-057d-4838-b80e-18245a8f535d,Bronze,75.36,Silver,76.19,88.89,30.23
47.62,Systemic Anti-Cancer Treatment (SACT) data for CPRD Aurum,1.1.7,ALLIANCE > CPRD,b4f6a5c2-e652-4972-9d06-510e9a469dfe,47.62,f8af632e-442d-4931-a370-b7fa2fa4b896,Not Rated,49.39,Not Rated,56.35,60.32,48.84
36.51,Cystic Fibrosis Patient Chronic Medication,1.1.7,ALLIANCE > CYSTIC FIBROSIS TRUST,b5033be2-0744-49c5-a398-a4d3ed4e1deb,95.24,0ad31772-0893-4cf7-bab0-683e80302201,Silver,83.66,Silver,81.75,100.0,27.91
55.56,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Episodes,1.1.7,ALLIANCE > NHS DIGITAL,b53f716d-a5c3-4ad8-a2aa-cae09c12ac18,61.9,ef22c16c-c294-46e1-abf9-5204212e9053,Not Rated,55.37,Not Rated,59.52,74.6,51.16
30.16,Radiotherapy Dataset,1.1.7,ALLIANCE > SAIL,b589b19b-b43f-4344-affb-5d7ea328c909,83.33,f102ca50-d1e4-44ec-924e-be89446652af,Silver,76.55,Silver,80.16,90.48,30.23
20.63,Cafcass England,1.1.7,ALLIANCE > SAIL,b70900e9-85e9-4dd2-ae4b-02523be4219d,95.24,8ee61578-e298-423a-be22-cb0438023e5c,Gold,88.32,Gold,89.69,100.0,18.6
20.63,Welsh Demographic Service (WDS),1.1.7,ALLIANCE > SAIL,b724a905-e8ae-4ab5-b543-91435f8d3514,95.24,8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d,Gold,88.32,Gold,89.69,100.0,18.6
20.63,Public Health England Seroepidemiology Unit,1.1.7,ALLIANCE > TISSUE DIRECTORY,b7a352ee-6306-4bd8-b9bc-f2a69fe17d70,69.05,89497432-17e0-49f4-96a4-65ef57d07701,Bronze,74.06,Bronze,69.84,60.32,20.93
20.63,Welsh Ambulance Services NHS Trust,1.1.7,ALLIANCE > SAIL,b8e0b4a8-aab6-47fc-ac6f-76cd5cdc933d,92.86,d415a5c5-8432-4a81-937f-12135ade6de7,Gold,87.13,Gold,88.89,98.41,18.6
22.22,ESPAC-TPlus,1.1.7,ALLIANCE > TISSUE DIRECTORY,b9642fb3-3bee-491b-8d83-22f9de0fd77f,69.05,47f979bc-da9d-4e9e-9f2b-15e09366db04,Bronze,72.89,Bronze,69.05,60.32,23.26
55.56,Mental Health Minimum Dataset v4 (Non-Sensitive) Events,1.1.7,ALLIANCE > NHS DIGITAL,ba071b0b-5ef4-457b-b194-3a69c2c71a06,64.29,3adeb2f4-a924-49cb-9537-84a9a4242a62,Not Rated,56.57,Not Rated,61.11,77.78,51.16
20.63,Assessment of ASHA’s workload and its determinants,1.1.7,HUB > BREATHE,bab944af-e345-4893-8640-a88aaff97c72,61.9,1a02bc11-a378-4f9e-82f9-c52674b388bd,Bronze,71.65,Bronze,66.67,53.97,18.6
42.86,Patient postcode linked deprivation measures for CPRD GOLD,1.1.7,ALLIANCE > CPRD,bc6ae5bc-7175-49e2-b093-337dde427736,50.0,f5c9ba01-a9cb-4a85-9850-d9466b2ff4fb,Not Rated,51.75,Not Rated,60.31,63.49,46.51
22.22,UK Biobank Assessment Centre,1.1.7,UK Biobank,bcb224fe-592f-4aaf-abd1-ad3e3caa61ff,40.48,2775b97f-1606-490e-81ef-35bad050434a,Not Rated,58.61,Not Rated,57.14,36.51,23.26
25.4,Emergency Department Data Set,1.1.7,ALLIANCE > SAIL,bd2d56db-f24b-4ac6-9201-3d68c65472b5,95.24,75c4dcb8-33bf-43f4-b2bb-db51b6621b2c,Gold,87.16,Gold,87.3,100.0,20.93
55.56,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Events,1.1.7,ALLIANCE > NHS DIGITAL,bdc17b2c-8b0f-4959-ab9b-e2de32d8a5f9,64.29,3d348613-2d66-4814-a294-7e0c365f43f8,Not Rated,56.57,Not Rated,61.11,77.78,51.16
47.62,Mother-Baby Link for CPRD GOLD,1.1.7,ALLIANCE > CPRD,bdcbbb2b-df99-4ae7-b36e-f266cfe10ed3,54.76,b734a1b5-37d3-4859-85d4-bf011df2a951,Not Rated,52.96,Not Rated,61.11,69.84,48.84
31.75,National Joint Registry - Revision Shoulder Replacement dataset,1.1.7,ALLIANCE > HQIP,bddcc89d-028f-48a5-b568-7dccd574563b,26.19,9623e62b-3c50-44aa-8923-0bbb94e7ad61,Not Rated,47.98,Not Rated,45.23,22.22,30.23
36.51,Oxford Healthcare Workers,1.1.7,ALLIANCE > OXFORD UNIVERSITY HOSPITALS,be1368c6-c97f-4ce0-8322-f97ccb28b9c3,59.52,9de2f365-4c5d-4252-acee-6270b113aa93,Not Rated,63.48,Not Rated,65.87,68.25,32.56
23.81,Barts CTU,1.1.7,ALLIANCE > TISSUE DIRECTORY,be77a483-2eff-4c05-8091-035fe79b3c8a,69.05,22aa219f-f3c8-4a25-822e-aa2504f6f29a,Bronze,72.89,Bronze,68.25,60.32,23.26
19.05,4 LMIC Asian Country ChrOnic: estimating respiratory disease burden in adults,1.1.7,HUB > BREATHE,be9bf427-d96d-4b1a-b1d1-83bdc3e8790b,69.05,490747bf-b268-41f3-8f35-f6bc4a4bdbfa,Silver,76.38,Bronze,69.84,58.73,16.28
23.81,NIHR BioResource: Metabolite data,1.1.7,ALLIANCE > NIHR BIORESOURCE,bf083b35-da74-4b82-87d3-203ba60325c6,59.52,dec09f2e-a93f-41e2-8217-72431ea4a19e,Bronze,68.13,Not Rated,62.7,49.21,23.26
23.81,Online questionnaires,1.1.7,UK Biobank,bf625cfe-c4b2-4ea8-bbe8-1a8873ca4cb9,38.1,8ef26f38-d1b3-4b24-b80a-717f216c6aea,Not Rated,56.26,Not Rated,55.55,34.92,25.58
41.27,TheatreEvents,1.1.7,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,bf83ada4-b72e-4789-b177-12a53aa763ea,16.67,2c6adf80-f30b-46c9-b9d4-fe3e68622469,Not Rated,37.41,Not Rated,36.51,14.29,41.86
22.22,Daisy Tumour Bank,1.1.7,ALLIANCE > TISSUE DIRECTORY,c03468f4-ba51-4d9f-a785-f041adb84724,71.43,b3ec5c18-e339-4bd8-8a59-5a3445a81f16,Bronze,74.09,Bronze,70.64,63.49,23.26
33.33,Vitamin D supplementation meta-analyses,1.1.7,HUB > BREATHE,c16605d7-6e6e-4461-bfab-107660e31427,28.57,2454a964-be58-4d1f-8f9a-ffae9db9129c,Not Rated,49.17,Not Rated,45.24,23.81,30.23
33.33,Hospital Episode Statistics Admitted Patient Care,1.1.7,ALLIANCE > NHS DIGITAL,c168178a-143b-402b-9ab4-2f230cf06226,78.57,2b6409db-a669-4bef-9fd5-39c2b6f8d5e9,Bronze,73.0,Silver,76.19,85.71,32.56
31.75,Cystic Fibrosis Patient Demographics,1.1.7,ALLIANCE > CYSTIC FIBROSIS TRUST,c1682cb7-8f43-49fa-b66a-0a4a205885d3,95.24,19bc55c2-13d7-4488-a52c-35287483ea4e,Silver,84.83,Silver,84.12,100.0,25.58
20.63,Assessing the eDPSEEA model in seasonal pollen induced asthma in Islamabad,1.1.7,HUB > BREATHE,c2548017-7913-40e1-bf98-aaa2e907b0ea,66.67,bfa012ad-e609-4d15-a824-6d143758ca4d,Bronze,74.03,Bronze,68.25,57.14,18.6
22.22,NICAM: Nilotinib treatment for c-KIT mutated advanced AMM,1.1.7,ALLIANCE > TISSUE DIRECTORY,c2c77d1a-d4d8-40cd-95f3-31912d4bd561,69.05,ba0edcaf-854d-4907-851a-280b56128b3b,Bronze,72.89,Bronze,69.05,60.32,23.26
25.4,Outpatient Referral,1.1.7,ALLIANCE > SAIL,c2ddca9f-f144-437b-ac7a-0a628a50ba1a,95.24,7465c65e-c321-42e9-a2f4-6bc664caf1fc,Gold,87.16,Gold,87.3,100.0,20.93
31.75,National Diabetes Audit,1.1.7,ALLIANCE > NHS DIGITAL,c2e112a0-a198-46b0-9a0c-ec91edfb6839,80.95,9a434a5c-563b-4da1-9133-9994960ade54,Bronze,75.36,Silver,77.78,87.3,30.23
17.46,Child Health Systems Programme - 4-5 year review,1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,c2ebe992-e9e8-4316-a565-20d312aa9ef7,76.19,5844bde6-628d-4e76-bb56-3534e2728eb6,Silver,79.95,Silver,82.54,82.54,16.28
22.22,TRICON8,1.1.7,ALLIANCE > TISSUE DIRECTORY,c3b4f4f2-953e-4470-bedd-9d09fd30a508,71.43,85113a93-89ed-40e3-a479-33b461b91858,Bronze,74.09,Bronze,70.64,63.49,23.26
34.92,Sentinel Stroke National Audit Programme Acute Organisational survey dataset,1.1.7,ALLIANCE > HQIP,c3d84dfa-fe3a-4b86-a0f5-efbe45aa93ad,26.19,fe6a4c83-f46f-4f61-8460-e120fdf8d864,Not Rated,46.81,Not Rated,43.65,22.22,32.56
33.33,Hospital Episode Statistics Critical Care,1.1.7,ALLIANCE > NHS DIGITAL,c476d414-8397-48a3-a0b3-95236b0c3515,78.57,80564a6b-1458-41de-a131-772eb93c0509,Bronze,73.0,Silver,76.19,85.71,32.56
38.1,HES Accident and Emergency data for CPRD GOLD,1.1.7,ALLIANCE > CPRD,c55b92d8-889d-435c-b0cb-2d9f7b432839,69.05,733b1060-f958-4c3e-ab6a-2b87901d9a9a,Not Rated,65.92,Bronze,69.84,77.78,37.21
39.68,Death Registration data for CPRD Aurum,1.1.7,ALLIANCE > CPRD,c577669a-a84f-493e-8164-3fe02f618561,69.05,ad8f07ef-a984-449b-8a60-d1dd564cc36d,Not Rated,64.76,Bronze,69.05,77.78,39.53
33.33,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - contextual data,1.1.7,ALLIANCE > HQIP,c5994fae-9c4a-47eb-ba42-85bd76e92879,26.19,4559a14f-563d-4fd2-93ae-27c6c0fd891e,Not Rated,46.81,Not Rated,44.45,22.22,32.56
42.86,Practice postcode linked deprivation measures for CPRD GOLD,1.1.7,ALLIANCE > CPRD,c6117afd-bc4d-404b-8d58-9d87db936b4c,50.0,3326d554-ca11-4dc6-aff0-c5b314442d27,Not Rated,51.75,Not Rated,60.31,63.49,46.51
36.51,PANTHER study,1.1.7,ALLIANCE > UNIVERSITY OF NOTTINGHAM,c66f943f-4307-4486-817c-49f6d8b9fd6b,57.14,596077a9-298b-44cc-aa7a-81f04cf5dcb3,Not Rated,62.29,Not Rated,65.08,66.67,32.56
55.56,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Episodes,1.1.7,ALLIANCE > NHS DIGITAL,c713773c-e961-400e-b44a-947002deb073,64.29,334afc50-a05a-43b9-aa1e-a012a22733e0,Not Rated,56.57,Not Rated,61.11,77.78,51.16
23.81,SCOT translational sample collection,1.1.7,ALLIANCE > TISSUE DIRECTORY,c78122ae-8be1-40d7-8567-b83059941c16,76.19,b3b790a7-a455-4efb-9c68-60e7131cb836,Bronze,75.31,Bronze,71.43,66.67,25.58
25.4,COVID-19 Consolidated Deaths,1.1.7,ALLIANCE > SAIL,c809126e-315b-4bcc-8fa3-741317bf9a4e,95.24,70e37f44-5c3e-4c83-a42a-89b3476d1d45,Gold,87.16,Gold,87.3,100.0,20.93
36.51,Tayside Microbiology: Tests,1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,c8516bb0-e4c5-484f-a370-f49315e3a330,21.43,826be5be-9977-49f9-b6d1-83ed9de08ebe,Not Rated,42.11,Not Rated,40.48,17.46,37.21
20.63,National Diet and Nutrition Survey (NDNS),1.1.7,ALLIANCE > TISSUE DIRECTORY,c960ffab-a94c-45e3-96a0-598719acfbf5,69.05,f86400cb-7cab-4e34-aab6-57138b6a96c2,Bronze,74.06,Bronze,69.84,60.32,20.93
55.56,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Records,1.1.7,ALLIANCE > NHS DIGITAL,c97b8058-a6a4-4c8d-92e1-6e9f4cddd301,64.29,01c88a30-b14d-401e-82bb-165cbde81942,Not Rated,56.57,Not Rated,61.11,77.78,51.16
36.51,Cystic Fibrosis Patient Annual Review Encounters,1.1.7,ALLIANCE > CYSTIC FIBROSIS TRUST,ca2c6ec0-00ce-42fc-a077-88911259576c,95.24,11360490-8da3-4a25-bb87-4fcc249b9af5,Silver,83.66,Silver,81.75,100.0,27.91
36.51,Cystic Fibrosis Patient Liver Enzyme,1.1.7,ALLIANCE > CYSTIC FIBROSIS TRUST,caa644b6-a50d-455b-bee1-96232443e2b9,95.24,f72e80fc-dcd3-4457-ae91-dd14449002dd,Silver,83.66,Silver,81.75,100.0,27.91
31.75,National Audit of Care at the End of Life - case note review,1.1.7,ALLIANCE > HQIP,cabb1db1-ee3e-42ce-a40b-468282e2011d,26.19,d8c67899-2d81-48c2-8482-31cd33973a36,Not Rated,47.98,Not Rated,45.23,22.22,30.23
41.27,Critical Care Minimum Dataset,1.1.7,ALLIANCE > BARTS HEALTH,cb020c3c-f738-4741-bf6b-3df16611b02e,19.05,c71fbdc3-0311-4b3f-a9ff-7d2f2c0ba993,Not Rated,38.59,Not Rated,37.3,15.87,41.86
23.81,UKCTOCS Longitudinal Women's Cohort (UKLWC),1.1.7,ALLIANCE > TISSUE DIRECTORY,cb7370a6-a1b0-4473-a32f-ec85ec0155a5,71.43,e0b951ba-0f7d-4743-9374-b965042accdd,Bronze,74.09,Bronze,69.84,63.49,23.26
34.92,National Early Inflammatory Arthritis Audit - organisational survey dataset,1.1.7,ALLIANCE > HQIP,cbda5643-96b7-4914-b990-a872e693ff29,26.19,a9ac99fe-32be-40ef-9509-03e6b2713ddf,Not Rated,46.81,Not Rated,43.65,22.22,32.56
55.56,Mental Health Minimum Dataset v4.1 (Sensitive) Records,1.1.7,ALLIANCE > NHS DIGITAL,cc383a3f-1c47-4b7d-99cf-be8ee0afe401,64.29,c00d5ad2-d5d2-4318-8849-4c2fe52aabd0,Not Rated,56.57,Not Rated,61.11,77.78,51.16
39.68,HES Admitted Patient Care data for CPRD Aurum,1.1.7,ALLIANCE > CPRD,cc3e20da-aca5-471d-a4bb-38e13f350f10,71.43,ed2de8fe-a204-4a4e-bcfa-9e3ad85e2fee,Not Rated,65.95,Bronze,69.84,79.37,39.53
22.22,National Cancer Registration Dataset 2018,1.1.7,ALLIANCE > PUBLIC HEALTH ENGLAND,cd0cc1de-f0bc-4247-9e67-47e162e2cc6b,73.81,267e13c1-d857-4702-853a-71abc34e6287,Bronze,75.28,Bronze,71.43,65.08,23.26
23.81,RIO,1.1.7,ALLIANCE > TISSUE DIRECTORY,cde234d0-748b-4df6-a59d-3268cc7e8c1d,73.81,18bc81e3-7d99-4152-bd7a-3c90ee7e489d,Bronze,74.12,Bronze,69.84,63.49,25.58
25.4,Postponed Admitted Procedures,1.1.7,ALLIANCE > SAIL,ce192e2e-4f31-4bb0-9c1f-5c4173c03011,92.86,bff94600-a254-4111-82f7-6167084d81ca,Silver,85.97,Gold,86.5,98.41,20.93
41.27,Maternity Services Dataset,1.1.7,ALLIANCE > BARTS HEALTH,ce1bcddb-a6af-4511-84c6-2a252d3eb202,19.05,173d07ab-5930-4d19-b3de-dcca193e62fd,Not Rated,38.59,Not Rated,37.3,15.87,41.86
33.33,North West London Community Data (NWL COM),1.1.7,HUB > DISCOVER NOW,ce896b89-5f4a-407c-bb10-7eec51089458,92.86,65dad445-ed81-4005-9f5a-4f8a7164043e,Silver,82.47,Silver,81.75,96.83,27.91
26.98,Improving Access to Psychological Therapies Data Set,1.1.7,ALLIANCE > NHS DIGITAL,cef00323-8756-4ea5-99e4-f12dcb2c6297,42.86,bcf6e5ce-986d-4b84-9c9c-69de966e8bbd,Not Rated,57.48,Not Rated,55.56,38.1,27.91
33.33,National Clinical Audit of Anxiety and Depression - spotlight audit on psychological therapies (clinical),1.1.7,ALLIANCE > HQIP,cf3f4336-e52d-4b82-8cc5-647dedaaee57,26.19,6c81b082-bdc5-4dcc-838a-e6e52e1be1cb,Not Rated,46.81,Not Rated,44.45,22.22,32.56
49.21,Quality of Life of Colorectal Cancer Survivors in England: Patient Reported Outcome Measures Survey for CPRD GOLD,1.1.7,ALLIANCE > CPRD,cf81a42f-2611-4410-89e9-7e3770d03a15,50.0,7e9d06a2-efe8-447f-ba3e-d4cbb7df2ef7,Not Rated,49.42,Not Rated,57.14,63.49,51.16
20.63,NIHR BioResource: Full Blood Counts,1.1.7,ALLIANCE > NIHR BIORESOURCE,cf8a9d13-0ee9-494d-b50d-cef39e7823c8,64.29,c20c2d81-c2d3-47cc-be38-93074467544c,Bronze,71.68,Bronze,67.47,55.56,20.93
25.4,Referral to Treatment Times,1.1.7,ALLIANCE > SAIL,cfdb9fbd-9f67-435c-b257-6b51430451bb,92.86,0bf54842-c1db-4bdb-9f55-c5be490bf758,Silver,85.97,Gold,86.5,98.41,20.93
20.63,Cancer Group CTR Cardiff trials,1.1.7,ALLIANCE > TISSUE DIRECTORY,d006821e-a507-4699-b560-b5d023e09d4b,69.05,cd833805-f0a8-4ddb-a50d-b12695c92120,Bronze,74.06,Bronze,69.84,60.32,20.93
23.81,Mental Health Inpatient and Day Case - Scottish Morbidity Record (SMR04),1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,d0137466-d07e-4bfd-817b-198086b9fa13,80.95,24de9d1a-1f48-4c10-b8fc-a3bd7449e191,Silver,78.84,Silver,81.75,87.3,23.26
50.79,NHS Tayside and Fife Haematology (Lab Data Restructured),1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,d05e9c8c-085e-4907-8688-cad494636ed8,35.71,c294bb01-062b-494e-942b-1efe8cbac3dc,Not Rated,44.6,Not Rated,47.62,46.03,46.51
58.73,Patient Reported Outcome Measures,1.1.7,ALLIANCE > NHS DIGITAL,d2af6a29-291b-4444-a17c-40f4208f1e1b,33.33,55614ed3-2484-4408-a4e9-e5fffed9e8e4,Not Rated,38.76,Not Rated,43.65,46.03,55.81
31.75,Education - Wales,1.1.7,ALLIANCE > SAIL,d2da2750-7482-4ce9-ae5c-2ab393408a67,95.24,204fa806-071d-4410-9c2c-143017d32d24,Silver,84.83,Silver,84.12,100.0,25.58
34.92,Sentinel Stroke National Audit Programme Clinical Dataset,1.1.7,ALLIANCE > HQIP,d3673b75-ec8f-4c2e-8c9b-6ef1d951f978,26.19,059a6495-a7d5-435b-8e2b-806c6ccccf2e,Not Rated,46.81,Not Rated,43.65,22.22,32.56
22.22,Strategy introducing Pulmonary Rehabilitation for COPD management in rural India,1.1.7,HUB > BREATHE,d3e859ba-cfb0-4eda-a14c-34b08d113cd9,59.52,e8afaf39-86fa-4085-a075-6118cc25fae0,Bronze,69.3,Not Rated,65.08,52.38,20.93
39.68,JANUS,1.1.7,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,d3fd4dac-2d15-401c-8185-905ee108d9ce,16.67,6590f79d-cfea-4695-9fe0-dc5f85e6d273,Not Rated,38.57,Not Rated,37.3,14.29,39.53
20.63,Exploration of Pneumonia Related Policy Formation and Implementation in Pakistan,1.1.7,HUB > BREATHE,d5446d68-2fb9-4f0f-962e-7b7ed484d534,66.67,e0d00cb7-62e1-4a38-8df6-cf537b59228d,Bronze,74.03,Bronze,68.25,57.14,18.6
25.4,Accelerometer,1.1.7,ALLIANCE > UK Biobank,d5649a81-5e75-45c2-ab89-3ce91f6d288b,40.48,ceab57e8-1e13-499b-a8f4-6ad60dad3721,Not Rated,56.28,Not Rated,56.35,38.1,27.91
39.68,OUH Patient Master Index,1.1.7,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,d57a096a-4fa3-4529-b508-0b9df0f1893c,16.67,5d7465f6-ced8-434b-9907-d357ad125024,Not Rated,38.57,Not Rated,37.3,14.29,39.53
23.81,INTERVAL,1.1.7,OTHER > The University of Cambridge,d58d02f1-47c2-44fc-b16e-4f6cbbb46e62,47.62,c1fa9b47-a954-4587-a0c2-bae0f3ec2b9b,Not Rated,61.02,Not Rated,59.52,42.86,25.58
36.51,TRACK-COVID,1.1.7,OTHER > UNIVERSITY OF CAMBRIDGE,d614f4fc-fae9-4775-86d9-4d4710017cf4,52.38,9e89af6b-bfa8-43dc-a2d4-5540c899a670,Not Rated,59.91,Not Rated,62.7,61.9,32.56
22.22,UNIRAD UK Sample collection,1.1.7,ALLIANCE > TISSUE DIRECTORY,d6296f3e-ccd9-46a5-acc9-50eb5aa41c56,69.05,a1d16f3f-c7e7-41c5-a071-07889bf49ab1,Bronze,72.89,Bronze,69.05,60.32,23.26
26.98,IBD NIHR BioResource: Demographic,1.1.7,HUB > GUT REACTION,d711d67c-7f48-4f9c-b482-ac3ed83f7990,92.86,b4121feb-f91b-4e20-a19b-fa49c7a5c1c1,Silver,84.8,Silver,84.92,96.83,23.26
25.4,Outpatient Appointments and Attendances - Scottish Morbidity Record (SMR00),1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,d8043751-28d6-4cfe-b860-757e592ab3cb,83.33,04cb9964-54fb-4529-b09b-735c3daa1c7b,Silver,78.88,Silver,82.54,90.48,25.58
38.1,Cancer Patient Experience Survey (CPES) for CPRD Aurum,1.1.7,ALLIANCE > CPRD,d90830f4-5aaa-4075-8c8d-839627224d16,33.33,fded6e24-8fef-47a4-a65e-9455bed043d3,Not Rated,45.73,Not Rated,46.83,31.75,41.86
31.75,National Vascular Registry -  Abdominal Aortic Aneurysm Repair clinical dataset,1.1.7,ALLIANCE > HQIP,da4d3e21-3d81-49e9-ada0-6175e2341190,26.19,fbe1ae63-0c12-48e5-be16-87d6bc7bd179,Not Rated,47.98,Not Rated,45.23,22.22,30.23
20.63,Looked After Children Wales,1.1.7,ALLIANCE > SAIL,da5098df-414f-48e0-aaa7-7e2277f80eb7,95.24,cfdafacb-48f0-4ad8-9f20-193a5eec2da4,Gold,88.32,Gold,89.69,100.0,18.6
20.63,King's Health Partners Cancer Biobank,1.1.7,ALLIANCE > TISSUE DIRECTORY,da9cdc4c-2790-47f4-b4b5-76e87ce450ae,69.05,a218d0b4-0273-4a04-ba17-c01dae6dcf33,Bronze,74.06,Bronze,69.84,60.32,20.93
33.33,NIHR BioResource: Sample holding,1.1.7,ALLIANCE > NIHR BIORESOURCE,dad781b9-43c2-4e8b-a377-e6c0f76d1c04,78.57,56993820-96e4-4a1f-9de1-bad53108c201,Bronze,74.17,Silver,76.19,85.71,30.23
55.56,Mental Health Minimum Dataset v4.1 (Sensitive) Events,1.1.7,ALLIANCE > NHS DIGITAL,db113fcd-69a0-4357-9c6d-250085deb3f5,64.29,a1154967-a80e-41da-a9ae-6183584ecf6b,Not Rated,56.57,Not Rated,61.11,77.78,51.16
36.51,"NHS Tayside, A&E Drugs given during an A&E visit",1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,dba474a3-90c4-423d-beb0-5ef79c490d24,21.43,acfbef89-344c-49a5-8079-7344f4316e0f,Not Rated,42.11,Not Rated,40.48,17.46,37.21
36.51,ONS 2011 Census Wales (CENW),1.1.7,ALLIANCE > SAIL,dbd69f22-2638-42a6-a936-069386e8eb7e,80.95,fc24482c-0f9b-445f-af7a-8598627c3b15,Bronze,75.36,Silver,76.19,88.89,30.23
20.63,NHS Greater Glasgow & Clyde Bio-Repository,1.1.7,ALLIANCE > TISSUE DIRECTORY,dcb4c87b-5884-41c0-b9af-d7d094dd0922,71.43,762976cc-83d0-4b31-a879-37f87f947406,Bronze,75.25,Bronze,71.43,63.49,20.93
36.51,"NHS Tayside A&E, Diagnosis dataset during A&E visit",1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,dd0ae281-e3b1-48fb-ad7a-c46565b577ce,21.43,14a39e96-8ac3-4df3-b42b-07718121c585,Not Rated,42.11,Not Rated,40.48,17.46,37.21
20.63,MesobanK,1.1.7,ALLIANCE > TISSUE DIRECTORY,ddbc149a-db56-41de-bd2c-3624149f6e7e,69.05,b03835b7-7408-49a0-a9aa-ea405f9855c9,Bronze,74.06,Bronze,69.84,60.32,20.93
31.75,National Vascular Registry Audit Carotid Endarterectomy Clinical Dataset,1.1.7,ALLIANCE > HQIP,ddc965e7-6f52-4eed-bed5-657e3e7bbeac,26.19,f857055b-c29e-4c7f-99ce-65f4ed59648e,Not Rated,47.98,Not Rated,45.23,22.22,30.23
20.63,NIMRAD-TRANS,1.1.7,ALLIANCE > TISSUE DIRECTORY,ddd49721-ff49-4f68-b3f5-e95a417fb0ac,69.05,039b55f7-d416-49ab-9bdb-4ff7dbc733df,Bronze,74.06,Bronze,69.84,60.32,20.93
33.33,National Bowel Cancer Audit -  Organisational Survey dataset,1.1.7,ALLIANCE > HQIP,de19b3ea-2600-4472-85e8-628e7beff76e,26.19,4e232aa8-ad56-4d82-adcc-cd06715a5c45,Not Rated,46.81,Not Rated,44.45,22.22,32.56
31.75,Medicines dispensed in Primary Care (NHSBSA data),1.1.7,ALLIANCE > NHS DIGITAL,de28157e-5319-4972-83ae-4d0c73cdfca9,76.19,f201b68f-d995-4a70-a9ee-aa3510232777,Bronze,71.81,Bronze,75.4,82.54,32.56
15.87,Children's Health in London and Luton (CHILL),1.1.7,HUB > BREATHE,de4b46f5-1591-442d-a896-6e0d91657c01,73.81,722be723-04bd-48b4-923b-e7d393f0c22b,Silver,78.77,Bronze,74.6,65.08,16.28
9.52,UK Lung Volume Reduction Surgery,1.1.7,HUBS > BREATHE,def6669b-0fac-485c-84b2-2ea83ec31123,80.95,9f98a674-12f6-42f4-b1a5-322b3b75eef1,Silver,85.83,Silver,80.96,71.43,9.3
31.75,Children’s Kidney Cancers - Great Ormond Street Hospital,1.1.7,HUB > DATA-CAN,df23aabd-3e5f-4fc2-aad6-af990cff6f19,95.24,3f71bef5-c5a2-400c-a482-2ad30b29a240,Silver,83.66,Silver,84.12,100.0,27.91
33.33,IBD NIHR BioResource: SNP chip data,1.1.7,HUB > GUT REACTION,df3cc57d-08ae-4e81-ae79-283d71cf8d95,90.48,3c749cfc-4008-4916-b64f-969d6a754c0f,Silver,81.28,Silver,80.95,95.24,27.91
31.75,School Workforce Annual Census (SWAC),1.1.7,ALLIANCE > SAIL,df514642-bf9d-432f-bf15-4d870fe4ae08,80.95,5692eade-5738-48ed-8527-39be9caaa7b5,Silver,76.52,Silver,78.57,88.89,27.91
23.81,Klang Asthma Cohort,1.1.7,HUB > BREATHE,df63e893-f688-4bb4-956c-cc4354bb4001,64.29,a2eddb27-c8bd-42ae-94f8-2a3026220da3,Bronze,71.68,Not Rated,65.88,55.56,20.93
36.51,Tayside Microbiology: Isolations,1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,dfb14598-b705-48c0-b6ec-4b84fa4ef1d4,21.43,eaa4bab0-0501-4511-aa2d-4e4fee0f0bf3,Not Rated,42.11,Not Rated,40.48,17.46,37.21
39.68,Admitted Patient Care Dataset,1.1.7,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,dfb21b3b-7fd9-40c4-892e-810edd6dfc25,16.67,b67f0edd-fed2-4d68-a25f-d225759aa3b0,Not Rated,38.57,Not Rated,37.3,14.29,39.53
20.63,Generation Scotland,1.1.7,ALLIANCE > TISSUE DIRECTORY,dfc3205c-3079-4e95-93e2-8a3a3beeea5a,69.05,019fad36-65ea-4d47-8d6d-a47240eeb801,Bronze,74.06,Bronze,69.84,60.32,20.93
31.75,National Oesophago-Gastric Cancer Audit - clinical dataset,1.1.7,ALLIANCE > HQIP,e10660af-b420-4e25-8fc9-ea451da1dcfb,26.19,306274ee-a098-43cc-b113-2df8116a8703,Not Rated,47.98,Not Rated,45.23,22.22,30.23
26.98,Coagulopathies & arterial/venous thrombosis in COVID patients: an OMOP dataset,1.1.7,HUB > PIONEER,e22f93fb-bc08-44eb-b292-dc2baf0ad343,78.57,dd4629c0-14b6-4cba-8dcf-31ec5fea68bb,Bronze,75.33,Silver,79.36,85.71,27.91
22.22,Healthcare Workers Risk Assessment,1.1.7,ALLIANCE > SAIL,e2f05904-723a-4d5c-8746-7ab3d1d94eef,92.86,ed131fee-0635-4613-a453-a383d5dd7cec,Silver,85.97,Gold,88.09,98.41,20.93
33.33,NIHR BioResource: Consent records,1.1.7,ALLIANCE > NIHR BIORESOURCE,e2f18151-1bce-4a54-ab32-af6296abdfda,76.19,1fb479b1-98d4-4d7b-91a2-8368ce3dc77c,Bronze,72.98,Bronze,74.61,82.54,30.23
22.22,"Leeds Dental Institute/School of Dentistry Leeds, Skeletal Tissues Bank",1.1.7,ALLIANCE > TISSUE DIRECTORY,e3373d01-48c6-49bc-8c9b-827831e525b3,69.05,f94168a1-cab8-4211-90e0-38a241609697,Bronze,72.89,Bronze,69.05,60.32,23.26
31.75,National Joint Registry - Primary Ankle Replacement dataset,1.1.7,ALLIANCE > HQIP,e38c8d6c-8655-4432-b654-23f89c0bb495,26.19,b8d009d0-0163-4aaf-8bd6-ad363c859862,Not Rated,47.98,Not Rated,45.23,22.22,30.23
20.63,eLIXIR - Early Life Data Cross-Linkage in Research,1.1.7,ALLIANCE > TISSUE DIRECTORY,e443bc67-bc8a-430b-88a9-d3380cd2ae38,71.43,c8cd0645-b728-4c62-84b8-036c1d8763be,Bronze,75.25,Bronze,71.43,63.49,20.93
33.33,Unified Cohorts Research Network,1.1.7,HUB > BREATHE,e516a359-74a8-4932-b4df-f2cf75eef89d,28.57,cffcf30d-cedb-421b-a5dc-6726633cb99a,Not Rated,49.17,Not Rated,45.24,23.81,30.23
36.51,National Records of Scotland (NRS) - Deaths Data,1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,e61fce14-617d-4f7b-80aa-468d94c6d897,85.71,e600dae2-a83c-4b7a-8d23-af4ac31ca374,Silver,78.9,Silver,77.78,92.06,27.91
17.46,Child Health Systems Programme - First Visit,1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,e6d1012e-4526-4f11-bff0-a24f0afea3aa,80.95,dec04153-f595-41ce-9d7e-5ef0c3fe8289,Silver,82.34,Silver,84.92,87.3,16.28
20.63,IDRIS Trial,1.1.7,ALLIANCE > TISSUE DIRECTORY,e7979d81-708d-4657-857c-4ca95d05cda2,71.43,8437b207-c925-4dd1-9478-5af329cd736e,Bronze,75.25,Bronze,71.43,63.49,20.93
30.16,COVID-19 Staff Testing of Antibody Responses Study (Co-STARS),1.1.7,ALLIANCE > GREAT ORMOND STREET HOSPITAL,e79c5f26-deb0-4531-834d-58912c9fe663,61.9,435bfcda-f378-44f6-9387-042d959eb945,Bronze,68.16,Bronze,69.84,69.84,25.58
34.92,Lifelong Learning Wales Record (LLWR),1.1.7,ALLIANCE > SAIL,e7fc3bb6-446b-4267-b563-bf6f94e8dee2,76.19,cba62a8d-5917-4912-ad4d-340472f7b904,Bronze,71.81,Bronze,75.39,85.71,32.56
25.4,Children Receiving Care and Support Census,1.1.7,ALLIANCE > SAIL,ea9fa5fb-928d-4736-8fbf-e3b58a49c6d6,95.24,fb3fac03-a428-4b3f-8058-5622e1fd57d8,Gold,87.16,Gold,87.3,100.0,20.93
39.68,Sunquest,1.1.7,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,eaca9ed1-30b6-4157-8894-8e53efc84849,16.67,a80b2567-4755-46f1-bd2a-f3817ce4f10c,Not Rated,38.57,Not Rated,37.3,14.29,39.53
34.92,NIHR BioResource: Contact detail,1.1.7,ALLIANCE > NIHR BIORESOURCE,eaf84760-348c-4a78-bd9f-489a5813276a,76.19,fc2fcaec-bd5b-4d43-9e0c-2fed36eff0e4,Bronze,71.81,Bronze,73.81,82.54,32.56
38.1,Covid-19 UK Non-hospital Antibody Testing Results,1.1.7,ALLIANCE > NHS DIGITAL,eb403f86-e169-4b40-b1e5-34658b90a4a9,76.19,a77e52cc-d404-45d6-835f-32e2dc46778a,Bronze,70.66,Bronze,73.02,84.13,34.88
50.79,Deaths General Registrar Office – National Records Scotland,1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,ecb404b5-2fcb-4b91-a86a-f9f8d25b2ebd,35.71,5362cfea-d554-43ba-916a-4460da39cc0c,Not Rated,44.6,Not Rated,47.62,46.03,46.51
22.22,"Introducing pulse oximetry in IMNCI, primary health facilities in Pune India",1.1.7,HUB > BREATHE,ecc4daf2-e58a-4ebc-9608-4bc741231fb9,59.52,dae5b81c-db28-414b-9328-5596632a8732,Bronze,69.3,Not Rated,65.08,52.38,20.93
20.63,NHS Grampian Biorepository,1.1.7,ALLIANCE > TISSUE DIRECTORY,ece82228-9af1-4699-a763-b4608908b645,71.43,10d0def8-dc03-473f-b60b-4c0dc3642a25,Bronze,75.25,Bronze,71.43,63.49,20.93
26.98,Patient Medical Card Registration (NI),1.1.7,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,ed02be36-22ff-4796-9394-5dd4524fea12,69.05,4e5ba567-c452-4979-8e2e-865f7df20252,Bronze,70.57,Bronze,74.6,76.19,27.91
23.81,The PEACE Study,1.1.7,ALLIANCE > TISSUE DIRECTORY,ee4a73ef-fb4e-4926-9fcc-db6b44b1447e,69.05,33b1a989-5f61-412e-bdae-b551c92d1ed6,Bronze,72.89,Bronze,68.25,60.32,23.26
20.63,GP Out of Hours,1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,ef3fbf5f-a87c-4f63-8d87-4a5f18fb4301,80.95,731dc868-3e79-4722-9b79-6bb8dec9435b,Silver,81.18,Silver,84.13,88.89,18.6
31.75,CPRD Aurum,1.1.7,ALLIANCE > CPRD,ef42201e-deb1-4675-896a-8a0162fe52a8,83.33,1d574c14-1af0-490d-9c4e-be88cfd0e345,Bronze,75.38,Silver,79.37,90.48,32.56
41.27,Freetext Dataset,1.1.7,ALLIANCE > BARTS HEALTH,ef727724-6c38-483b-b28d-8e94b5a9d7ac,19.05,0f07f939-1265-4e8b-aaa6-d897d254c2f3,Not Rated,38.59,Not Rated,37.3,15.87,41.86
34.92,National Cardiac Audit Programme - National Heart Failure Audit,1.1.7,ALLIANCE > HQIP,efbb3bf4-834b-417e-b002-03fc41715e58,26.19,834618f3-0c6d-4ed2-abae-39208c6b3080,Not Rated,46.81,Not Rated,43.65,22.22,32.56
20.63,The Malaysian Asthma Hajj Study,1.1.7,HUB > BREATHE,eff41dbc-0ce4-4bfe-b51f-7b2753750332,57.14,8187f77f-65e3-435e-ad7e-d7f22e2fcf80,Bronze,69.27,Not Rated,64.29,49.21,18.6
33.33,Welsh Health Survey Dataset,1.1.7,ALLIANCE > SAIL,f0fc13b4-f801-4647-82f3-07ed07f26ea0,83.33,e4d8edb3-6e8e-435d-9732-60c83027d8f9,Silver,76.55,Silver,78.58,90.48,30.23
38.1,North West London Acute Patient level Data (NWL Acute PLD),1.1.7,HUB > DISCOVER NOW,f2268d4e-0149-4913-9832-0399960eecd4,80.95,0d5a40e6-52c0-43c4-bd9f-f2a803cc8ff6,Bronze,74.19,Bronze,74.6,87.3,32.56
41.27,"Problems, Diagnosis and Procedures",1.1.7,ALLIANCE > BARTS HEALTH,f2b4211b-1af7-46ff-82a3-35b29d1d478e,19.05,51b41359-1558-48df-9950-88f75ca6ac4c,Not Rated,38.59,Not Rated,37.3,15.87,41.86
42.86,Practice postcode linked deprivation measures for CPRD Aurum,1.1.7,ALLIANCE > CPRD,f3a53f7a-ea93-4b9e-bccd-afe762259044,50.0,9f689ef4-26c6-4f85-80ff-5116974f315a,Not Rated,51.75,Not Rated,60.31,63.49,46.51
25.4,National Joint Registry - Primary Knee Replacement dataset,1.1.7,ALLIANCE > HQIP,f4915e4b-639c-45ae-9b0f-afab547e1104,71.43,d517e6fc-9a88-4647-b787-dcbed3635885,Bronze,72.93,Bronze,69.05,63.49,25.58
31.75,GPES Data for Pandemic Planning and Research (COVID-19),1.1.7,ALLIANCE > NHS DIGITAL,f56d5407-4a7e-420e-8479-87b075da2b39,83.33,696cfc9f-090d-4328-94ac-140760a77c73,Bronze,75.38,Silver,79.37,90.48,32.56
36.51,NHS Tayside and Fife Immunology (Extractable),1.1.7,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,f57d92d9-5288-4b4d-9790-49863e8b9232,21.43,39055449-c074-4b58-adb2-b1c0d2441c4d,Not Rated,42.11,Not Rated,40.48,17.46,37.21
31.75,National Diabetes Inpatient Audit - Harms clinical dataset,1.1.7,ALLIANCE > HQIP,f69d1b15-a0b4-461a-8aff-dba56da0791f,26.19,f1471a45-a6f4-4ed7-96b0-56a1af21086e,Not Rated,47.98,Not Rated,45.23,22.22,30.23
25.4,Substance Misuse Dataset,1.1.7,ALLIANCE > SAIL,f6aa8836-b437-40b6-bd1e-ae20010048dd,95.24,291c0dd4-0988-42d2-8e0b-878a892add57,Gold,87.16,Gold,87.3,100.0,20.93
30.16,North West London Integrated Care Record (NWL ICR),1.1.7,HUB > DISCOVER NOW,f6e25ba4-4f7a-436e-a5f9-f0257d45a612,92.86,602d8093-6a1e-42cf-a89c-8bf0d47ecc8c,Silver,82.47,Silver,83.34,96.83,27.91
20.63,PHOTO Translational bladder cancer biorepository,1.1.7,ALLIANCE > TISSUE DIRECTORY,f71e0f89-edf6-4070-9045-6024b00f79ca,71.43,07d1b768-78f6-41e8-995a-66afd2549b34,Bronze,75.25,Bronze,71.43,63.49,20.93
26.98,Developing and evaluating interventions to improve asthma care: HEAL ASTHMA,1.1.7,HUB > BREATHE,f73627e3-bd7c-4be2-81b4-3baf846ab787,66.67,216924f0-585e-4842-a165-78cf9e0af0aa,Bronze,70.55,Not Rated,65.08,57.14,25.58
31.75,National Maternity and Perinatal Audit clinical audit,1.1.7,ALLIANCE > HQIP,f806fe65-79aa-4843-bc56-a08bf14ffcec,26.19,1419533e-3d46-4d8a-992b-b5311e6bd27b,Not Rated,47.98,Not Rated,45.23,22.22,30.23
33.33,"Maternal, Newborn and Infant Clinical Outcome Review Programme - perinatal surveillance dataset",1.1.7,ALLIANCE > HQIP,f82b8ca5-5a52-4502-bf78-cfbb718cbe2f,26.19,11deee42-5876-4ebe-acca-e996702e1343,Not Rated,46.81,Not Rated,44.45,22.22,32.56
17.46,Child Health Systems Programme - 13-15 Month Review,1.1.7,ALLIANCE > PUBLIC HEALTH SCOTLAND,f87064b0-cb12-4e6e-a709-52e776a0f6b7,78.57,e77af7a3-32fa-4a08-8455-4fb489e5b64a,Silver,81.14,Silver,84.12,85.71,16.28
34.92,IBD NIHR BioResource: Case report form,1.1.7,HUB > GUT REACTION,f88440b9-53fc-49df-82dd-9cdd3309bd36,90.48,877a7275-b99d-4ed4-9691-de577e0ab49e,Silver,80.12,Silver,80.16,95.24,30.23
22.22,Wellcome Sanger Institute: Whole Exome Sequencing,1.1.7,HUB > GUT REACTION,f88fa262-525a-4d8a-94bd-cb6f5e7efbf7,59.52,cd20517c-2f75-40e9-9ee8-563d32624b55,Bronze,68.13,Not Rated,64.28,50.79,23.26
26.98,Ventilation strategies for patients on intensive care,1.1.7,HUB > PIONEER,f8a268c1-831c-4c80-b62c-e254a572b9a0,76.19,1a66dbc1-4f06-455c-85fc-68b372575cad,Bronze,74.14,Silver,78.57,84.13,27.91
26.98,Real-time Assessment of Community Transmission (REACT) Study 2: COVID antibody,1.1.7,ALLIANCE > IMPERIAL COLLEGE LONDON,f9959c00-c063-4fbf-933d-755e3b6ecedc,40.48,70656016-c1c9-4bc2-93d1-c66341fcdf36,Not Rated,56.28,Not Rated,54.77,36.51,27.91
20.63,Tommy's National Reproductive Health Biobank,1.1.7,ALLIANCE > TISSUE DIRECTORY,f99d82da-13eb-42db-ad0d-348be2173535,71.43,20639743-9a28-43dd-a8af-7571ece2a7f8,Bronze,75.25,Bronze,71.43,63.49,20.93
22.22,PHOENIX DDR-Anti-PD-L1 Trial,1.1.7,ALLIANCE > TISSUE DIRECTORY,f9c40294-92d8-45cd-b11a-70eb0fc09004,71.43,df94730b-374b-4d91-8116-1c10a7c77c4e,Bronze,74.09,Bronze,70.64,63.49,23.26
34.92,Genvasc Primary Care Data,1.1.7,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,fa179e24-2068-4c34-b73c-230003010e9f,30.95,f397acff-a7af-4062-8e8b-c85889cc41df,Not Rated,48.04,Not Rated,45.24,25.4,34.88
34.92,National Cardiac Audit Programme - National Adult Cardiac Surgery Audit (NACSA),1.1.7,ALLIANCE > HQIP,faf7ec31-999a-4d87-9d6d-8837ff2fa486,26.19,5f37e3c2-b5ac-43eb-8eba-ac94dbbff103,Not Rated,46.81,Not Rated,43.65,22.22,32.56
25.4,NIHR BioResource: Returned datasets,1.1.7,ALLIANCE > NIHR BIORESOURCE,fb274dd9-27ab-4eac-9432-90373a9837e6,57.14,261bcf76-8621-4f0d-b2e6-310993d73daa,Not Rated,65.78,Not Rated,61.11,47.62,25.58
26.98,Hospital Inpatient data,1.1.7,UK Biobank,fb2a851b-3f1c-4665-bbdb-5461f1f36bca,42.86,97c68424-dc80-4faa-b777-67c42f92a9b6,Not Rated,56.31,Not Rated,55.56,38.1,30.23
20.63,Breast Test Wales,1.1.7,ALLIANCE > SAIL,fb4a069b-fd74-47b2-bbb1-9cde6b590d66,95.24,8b9efd45-f56d-4aa3-b2b8-c66ff3813a2b,Gold,88.32,Gold,89.69,100.0,18.6
25.4,NIHR BioResource: Whole Genome Sequencing,1.1.7,ALLIANCE > NIHR BIORESOURCE,fbad23e8-5079-4f11-b8b7-aaa01c0fbc4b,61.9,ecb90b4a-6f4f-4398-a4f6-d64891c4a137,Bronze,68.16,Not Rated,63.49,52.38,25.58
31.75,North West London High Cost Drugs Data (NWL HCD),1.1.7,HUB > DISCOVER NOW,fc704af0-368b-4dd0-866f-753b6d1dccf8,92.86,75638d2c-556a-46b6-afcc-7ab425b34679,Silver,83.64,Silver,82.54,96.83,25.58
39.68,CellPath,1.1.7,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,fc7b44f0-eb69-4257-8c07-7516c1210c46,16.67,c4538af4-505f-45df-aeae-788ddfd7cb54,Not Rated,38.57,Not Rated,37.3,14.29,39.53
20.63,Infectious Diseases BioBank at King's College London,1.1.7,ALLIANCE > TISSUE DIRECTORY,fd2317ea-c729-433b-b578-309118118b78,69.05,47b544f4-301c-43e0-b347-fc623ea1a8b3,Bronze,74.06,Bronze,69.84,60.32,20.93
20.63,Bristol Biobank,1.1.7,ALLIANCE > TISSUE DIRECTORY,fe3f2246-aec4-4be4-8f51-3e5bde80931d,69.05,9d56ae46-5955-4f03-a93c-a4a6d9f641ab,Bronze,74.06,Bronze,69.84,60.32,20.93
31.75,National Joint Registry - Primary Shoulder Replacement dataset,1.1.7,ALLIANCE > HQIP,fe4662ad-9080-4bd8-8de4-51195d275d5b,26.19,0e903b9e-a329-478a-937c-480eecee4996,Not Rated,47.98,Not Rated,45.23,22.22,30.23
36.51,National Paediatric Diabetes Audit - Parent and Patient Recorded Experience measures,1.1.7,ALLIANCE > HQIP,fe872375-2401-4de1-9650-d4139cf5793a,26.19,b0979e07-3331-408f-853b-5eeba80ce8f9,Not Rated,45.66,Not Rated,42.86,22.22,34.88
33.33,UHB 100K Genomics patient clinical data including their acute care contacts,1.1.7,HUB > PIONEER,fed0d62b-f7f7-475c-89c9-67caa374f970,88.1,ceae4fe0-4e98-4e3c-85db-e86539aade81,Silver,77.77,Silver,80.95,95.24,32.56
20.63,REQUITE,1.1.7,ALLIANCE > TISSUE DIRECTORY,fede80e2-aea9-4229-8024-39b09110be7b,69.05,b5217dcb-582f-4914-ae45-9eb3899add30,Bronze,74.06,Bronze,69.84,60.32,20.93
55.56,Mental Health Minimum Dataset v4 (Non-Sensitive) Records,1.1.7,ALLIANCE > NHS DIGITAL,ff2c6982-00f3-4483-9fc2-19b3a7211d8d,64.29,b9f24f81-bcf2-4e47-8909-0d5414e2d7a4,Not Rated,56.57,Not Rated,61.11,77.78,51.16
20.63,IMPORT HIGH trial blood samples,1.1.7,ALLIANCE > TISSUE DIRECTORY,ff8231e5-3ede-4844-a21b-b1d05120e07e,71.43,edafebac-9479-4d2c-b44e-349091d5b35b,Bronze,75.25,Bronze,71.43,63.49,20.93
20.63,Teleconsultation in remote rural India: management of COPD and Asthma,1.1.7,HUB > BREATHE,ffc34689-1a81-4f56-9c3f-e62b76d8445b,64.29,de496590-26b3-4e74-bc5e-1ff5c83f5b43,Bronze,72.84,Bronze,67.47,55.56,18.6
